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xABSTRACT
Statistics is a powerful tool in different scientific fields by providing statistical supports
in experimental designs, data processing and statistical inference. In this thesis, we con-
duct theoretical and methodological statistical research with applications in biological and
genomic areas.
In Chapter 2, we study the statistical testing problems with order-restricted null hy-
pothesis, where the null parameter space is a union of two disjoint convex cones. We derive
the likelihood ratio test and the intersection-union test, and show that the likelihood ra-
tio test is uniformly more powerful than the intersection-union test. We also discuss the
possibility of developing a test uniformly more powerful than the likelihood ratio test.
In Chapter 3, we propose four testing procedures for detecting the monotonic changes in
multivariate gene expression distributions. We consider cases in which the treatment factor
is ordinal and can be naturally ordered. The proposed procedures focus the detection powers
to genes with monotonic departures from mean equality. Also, the proposed methods are
able to deal with small sample sizes and high-dimensional distributions.
In Chapter 4, we propose a new methodology, based on a hidden Markov model with
emission probabilities that are governed by mixture distributions, to detect copy number
variations between different genomics using next generation sequencing read counts. This
method demonstrates an improvement comparing to existing methods. We use this method
to identify copy number variations between two maize genotypes, and the result is concor-
dant to previous genomic studies using microarray data.
This thesis concludes in Chapter 5, which provides a discussion of future research direc-
tions.
1CHAPTER 1. General Introduction
1.1 Introduction
Statistics is a powerful tool in various scientific areas, providing theoretical and method-
ological support in experimental designs, data processing and statistical inference. Con-
versely, questions raised in scientific studies motivate new research topics in statistical
theories and methodologies. In this thesis, we focus on applications of statistical methodol-
ogy in biological research and genomic studies. In this chapter, we briefly introduce several
basic concepts and ideas that are covered in this thesis.
1.2 Order Restricted Statistical Inferences
In many scientific experiments, only parts of the parameter spaces are possible or con-
form to scientific limitations. For example, some treatment factors are quantitative or
ordinal that can be naturally ordered. As the treatment level increased, it is reasonable to
assume that the response values change monotonically if it is associated with the treatment
factor. In these cases, it is of greater practical interest to study the statistical inference with
parameters constrained to a sub-space with order restrictions than over the whole space.
For a more specific example, as the dose of a drug increased within some range the
plasma concentrate of the drug is increased, and the drug effect may be strengthened. To
search for the molecular genetic mechanisms that govern this phenomenon, gene expression
values under different experiment levels are measured. We may wish to find genes with
monotonic changes in mean expressions. In this example, suppose µi i = 1, 2, 3 is a mean
gene expression value for the ith treatment level. The null hypothesis associated with
homogeneity is
µ1 = µ2 = µ3,
2µ1 = µ3
µ 2
=
µ 3
µ
1 =
µ
2
µ1<µ2<µ3
µ3<µ2<µ1
H0: µ1=µ2=µ3
Figure 1.1: The null and alternative spaces in the dose-response example
and the alternative hypothesis associated with the monotonic alternative is
µ1 ≤ µ2 ≤ µ3 or µ1 ≥ µ2 ≥ µ3
with at least one inequality hold. Figure 1.1 shows the null and the alternative parameter
spaces projected onto a two-dimensional sub-space in this example. The point in the center
denotes the null space, and the shaded area denotes the alternative space.
Another example is the heterosis phenomenon in hybridazation. One kind of heterosis
is also called hybrid vigor. It occurs when the mean trait value of the offspring is more
extreme than both of its parents. The maize F1 hybrid offspring from a cross of the parental
inbred lines B73 and Mo17 has a series of improved trait characteristics, such as larger crop
size, lower maturation time, and higher grain yield (Hallauer and Miranda, 1981). Suppose
θi i = 1, 2, 3 is the mean measurement of a trait of interest, with i = 1 for one parent, i = 3
for another parent, and i = 2 for the offspring. The null hypothesis of no heterosis can be
expressed as:
θ1 ≤ θ2 ≤ θ3 or θ1 ≥ θ2 ≥ θ3,
3θ1 = θ3
θ 2
=
θ 3
θ
1 =
θ
2
θ1<θ2<θ3
θ3<θ2<θ1
θ2 < min{θ1,θ3} <θ2max }θ3,θ1{
Figure 1.2: The null and alternative spaces in the heterosis example
and the alternative hypothesis of heterosis is:
θ2 < min{θ1, θ3} or θ2 > max{θ1, θ3}.
Figure 1.2 shows the null and the alternative parameter spaces of the heterosis example
projected onto a two-dimensional sub-space. The unshaded area is the null space, and the
shaded area is the alternative space.
There is a long history of research on univariate testing problems involving order re-
stricted alternatives. Some of the earliest work was conducted by Bartholomew (1959a,
1959b, 1961a, 1961b). A large amount of research work in this area is summarized in
Robertson, Wright and Dykstra (1988) and reviews for recent work can be found in Silva-
pulle and Sen (2005). However, most of the existent work is related to the null or alternative
space restricted to a single cone. There is little work with parameter constrained to a union
of cones.
In Chapter 2, we consider the heterosis example discussed above, where the null hy-
pothesis space is a union of two cones. With the assumption that the random variables
4independently follow normal distributions, we derive the likelihood ratio test, and discuss
the situations in which the uniformly more powerful tests can be constructed and their
practical applicabilities.
In Chapter 3, we consider the example of monotonic gene expressions under ordinal
treatment levels, with the condition that genes are grouped together into gene sets so that
we have large random variable dimensions but small sample sizes. We propose several
nonparametric procedures that have good performace on detecting multivariate gene sets
with monotonic changes in gene expression distributions.
1.3 the Intersection-Union Test
In the heterosis example mentioned above, the null hypothesis is a union of two cones:
ΘI = {θ : θ1 ≤ θ2 ≤ θ3}, ΘII = {θ : θ1 ≥ θ2 ≥ θ3}. As a result, it is natural to consider an
intersection-union test (IUT). The intersection-union test was first described by Lehmann
(1952) with the name coined by Gleser (1973). In this heterosis example, the null hypothesis
H0 can be expressed as θ ∈ Θ0 = ΘI ∪ ΘII , and the alternative H1 can be expressed as
θ ∈ Θ1 = ΘcI ∩ΘcII . Let RI be the rejection region for a test of
H0I : θ ∈ ΘI vs. H1I : µ ∈ ΘcI ,
and RII be the rejection region for a test of
H0II : θ ∈ ΘII vs. H1II : µ ∈ ΘcII ,
then the intersection-union test (IUT) based on RI and RII rejects H0 in favor of H1 if
and only if the test for H0I vs. H1I and the test for H0II vs. H1II both reject the null
hypotheses. Berger (1982) showed that if each of the tests corresponding to RI and RII is
of level-α, then the IUT corresponding to R = RI ∩ RII is also of level no larger than α.
By this means, the size of the IUT is no larger than α, but it might be very conservative.
1.4 Gene Set Testing
In gene expression studies, we have to deal with thousands of response variables cor-
responding to gene expressions for thousands of genes. However it is difficult to extract
meaningful biological interpretations from single genes. To improve the interpretability,
5genes are grouped into gene sets, based on the prior knowledge that some genes are asso-
ciate with each other. The Gene Ontology (GO) is such a database that provides biological
annotations for genes, by using the knowledge of some genes are associated with each other
in aspects of cellular components, molecular function, and biological process, which provides
a basis to group genes into gene sets.
There has been a large body of work in the area of detecting gene sets with joint
expression distributions changing across treatment levels. Among many well-known gene
set testing methods and softwares, some use gene specific statistics. These include the
GSEA by Subramanian et al. (2005), the SAFE by Barry et al. (2005), and the GSA by
Efron and Tibshrani (2007), among others. Some other methods use global and multivariate
gene set testing, which include Goeman’s Global Test (Goeman et al, 2004), the ANCOVA
global test by Mansmann and Meister (2005), the Multiresponse Permutation Procedure
(MRPP) described by Mielke and Berry (2001) and used by Nettleton et al. (2008) in gene
set testing, and the HMM aproach using the directed acyclic graph (DAG) by Liang and
Nettleton (2010), among others.
1.5 Copy Number Variation Detection Using Next Generation
Sequencing Data
A copy number variation (CNV) is a variation between differenct genomics in the number
of copies in a genomic region for at least 1000 DNA bases or larger (Banerjee et al., 2011).
Maize exhibits extensive genotypic and phenotypic variations. Since the maize genotype
was fully sequenced using whole-genome sequencing technologies in 2009 (Schnable et al.
2009), there is a large body of research work on CNVs detections among various maize
genotypes using array comparative genomic hybridization (aCGH) (Swanson-Wagner et al.,
2009; Springer et al., 2009; Belo et al., 2010). Although aCGH has served as a robust and
effective approach for CNV identification since it was proposed in 1997 (Solinas-Toldo et
al, 1997), it is expensive and has limited resolution and accuracy. Recently developed next
generation sequencing (NGS) technologies provide a sensitive and accurate approach for
genomic variation detections.
However, the use of NGS for CNV detection has been limited by a lack of available
and effective statistical approaches. Most of the existing methods for CNV identification
6using NGS data can be classified into two categories. One category contains the sliding
window methods. The common idea of the sliding window methods is to divide the whole
genome into small windows, then to carry out tests of significance for copy number variance
between any adjacent windows. The category of sliding window methods includes the Segseq
by Chiang et al. (2009), Event-wise testing by Yoon et al. (2009), the rSW-seq by Kim et
al. (2010) and the JointSLM by Magi et al. (2011), among others. The sliding window
methods face the problem of a huge number of simutaneous tests they heavily rely on the
determination of the critical values. The other category includes methods using Hidden
Markov Models. Ivakhno et al. (2010) proposed the CNAseg HMM based method, using
multiple sequensing samples for each of the genotypes in the CNV detection.
Chapter 4 proposes a new CNV detection methodology for NGS data originating from
two different genomes, using a Hidden Markov Model approach. We use the Expectation-
Maximization (EM) algorithm to obtain estimates for the parameters in the model. An
introduction to some basic ideas of HMMs and the EM algorithm is provided in Sub-sections
1.5.1 and 1.5.2.
1.5.1 Hidden Markov Models
A Hidden Markov Model (HMM) is a probabilistic model based on a Markov process.
The theory of the HMM was published in a series of paper by Baum et al. (1966, 1967,
1970, 1972). A HMM is constructed from a bivariate random process with discrete time,
{St, Xt}, t = 1, 2, . . .. Here St, t = 1, 2, . . . , T is an invisible Markov chain with finite
states, where the next state and past states are independent given the current state St, i.e.,
P (St+1|S1, . . . , St) = P (St+1|St). Xt is a visible observation generated by the hidden state
St, t = 1, 2, . . . , T . Depending on the current state St, the observation Xt is independent
of all other states and observations. Each state has a probability distribution in generating
the observations. The information about the HMM is provided by the observations Xt,
t = 1, 2, . . . , T .
A HMM is defined by three probabilities. First is the transition probability P (St+1|St),
which is the conditional probability of the next state given the current state. The transition
probabilities determine the associations among the hidden states. Another is the conditional
probability of having an observation Xt given the current state St, which is called the
7emission probability. The emission probabilities determine the intrinsic relation between
the hidden states and the visible observations. The third is the initial probability of the
hidden state at time one, P (S1). The transition probability, the emission probability and
the initial probability are the three essential probabilities through which we can reveal a
HMM.
1.5.2 The Expectation-Maximization Algorithm
The Expectation-Maximization (EM) algorithm is an iterative procedure searching for
the parameter values that maximize the likelihood function, when part of the data set is
missing. With this feature, the EM algorithm is also an effective method in estimating the
parameters and predicting the hidden state in HMMs, by assuming X = (X1, X2, . . . , XT )′
as the incomplete data and the hidden states S = (S1, S2, . . . , ST )′ as the missing data. The
complete data is (X,S). The target likelihood to be maximized is represented as L (θ|X).
SinceX is the incomplete data,L (θ|X) is also referred to as the incomplete data likelihood.
If the value of S were known, then the complete data likelihood would be L (θ|S,X). With
some initial estimation of the parameter value θ(0) using the simplest assumptions, the first
step of the EM algorithm is to evaluate the expectation of the complete data log-likelihood,
with respect to the conditional distribution of the missing data S, given the observed data
X and the current parameter θ(0): ES|X,θ(0)(`(θ|X,S)). This step is call the E-step of
the EM algorithm, and ES|X,θ(0)(`(θ|X,S)) is a function of θ. The second step of the EM
algorithm is to maximize ES|X,θ(0)(`(θ|X,S)) with respect to θ, which gives an updated
parameter value θ(1). This step is call the M-step of the EM algorithm. By iteratively
applying the E-step and the M-step, a sequence of parameter values
{
θ(m)
}
m≥0 is obtained,
where each θ(m) increases the value of L (θ|X) with respect to the previous step θ(m−1).
The iteration stops when the amount of enlargement of the likelihood is sufficienly small.
1.6 Organization
The main idea throughout this thesis is statistical theory and methodology research
with motivations from biological and genomic areas. Chapter 2 studies statistical inference
with an order-restricted null hypothesis, where the null parameter space is a union of two
cones. This test can be applied to detect heterosis in trait values between the parents in-
8bred lines and their hybrid offsprings. Chapter 3 studies monotonic alternative hypothesis
testing with high-dimensional random variables and small sample sizes, which can be ap-
plied to multivariate gene set detections using microarray gene expression data. Chapter 4
proposes a new methodology based on a Hidden Markov Model with mixture emission prob-
abilities, which can be employed in copy number variation detections using next generation
sequencing data.
Chapter 2 derives the likelihood ratio test (LRT) and the intersection-union test (IUT)
when the null parameter space is a union of two cones and the alternative space is the com-
plimentary set of the null space. We prove that the likelihood ratio test is uniformly more
powerful than the intersection-union test. We also demonstrate the existence of the tests
that are uniformly more powerful than the likelihood ratio test in some related problems,
and discuss the applicability of these uniformly more powerful tests in real data analyses.
An analysis of maize gene expression data of two inbred lines and their hybrid F1 offspring
is used to illustrate the application of union-of-cone null hypothesis testing in heterosis
identifications.
Chapter 3 considers the case when the null hypothesis of homogeneity of distributions
and the alternative hypothesis of monotonic order-restricted of means, with random vari-
ables with relatively large dimensions and small sample sizes. The hypotheses are motivated
by multivariate gene set testing with expression levels that change monotonically with an
ordinal treatment factor. We propose four nonparametric tests based on permutation pro-
cedures. A simulation study is carried out to compare the proposed tests with tests not
focusing on monotonic alternatives, and it is shown that the proposed tests provide better
detection power for gene sets with monotonic changing trends.
Chapter 4 explores a new statistical methodology, based on a Hidden Markov Model with
mixture emission distributions (m-HMM), to detect copy number variation change points
in comparing next generation DNA sequences between a target genome and a reference
genome. The Expectation-Maximization algorithm is used to estimate the parameters and
predict the hidden states in the m-HMM.
Conclusions and additional discussion are provided in Chapter 5, with an overview of
future work.
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CHAPTER 2. Testing a Union-of-Cones Null Hypothesis for the
Identification of Heterosis
Abstract
High-parent or low-parent heterosis is a genetic phenomenon that occurs when the mean
trait value of offspring is more extreme than that of either parent. We discuss statistical
tests that can be used to detect heterosis of this type. The null hypothesis of no high-parent
or low-parent heterosis constrains a vector of mean parameters to a union of two closed con-
vex cones. This unusual null parameter space leads to a non-standard testing problem for
which we derive both the likelihood ratio test and the intersection-union test. Although
these tests are often equivalent, we show that the likelihood ratio test is preferred over the
intersection-union test in this case. Moreover, we also discuss the possibility of developing
a test uniformly more powerful than the likelihood ratio test. Although such tests are of
theoretical interest, we ultimately recommend the likelihood ratio test for use in practical
applications.
KEY WORDS: Cone; Intersection-Union Test; Likelihood Ratio Test; Order-restricted Sta-
tistical Inference; Uniformly More Powerful Tests
2.1 Introduction
One form of heterosis, also known as hybrid vigor, occurs when the mean trait value
of offspring is more extreme than that of either parent. For example, the maize F1 hybrid
offspring produced from a cross of parental inbred lines B73 and Mo17 is larger in size, has
lower maturation time, and has higher grain yield than both of its parents (Hallauer and
Miranda, 1981). The hybrid vigor phenomenon was first documented in the late 1800s and
is the basis of the multibillion dollar seed industry today.
When two inbred parental lines are crossed to produce hybrid offspring, it is natural to
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ask whether there is evidence of heterosis for a trait of interest. The purpose of this paper
is to develop a method that can be used to test for heterosis using measures of a trait of
interest from multiple parent and offspring replications. We illustrate our proposed method
in Section 2.6 using measures of gene expression levels in B73, Mo17, and F1 hybrid maize
lines originally studied by Swanson-Wagner et al. (2006).
Formally, the testing problem that we consider can be described as follows. Suppose for
i = 1, 2, 3 and j = 1, . . . , n,
yij = µi + ij ,
where µ1, µ2 and µ3 are unknown parameters in R and 11, . . . , 3n
iid∼ N(0, σ2). We wish
to test
H0 : µ1 ≤ µ2 ≤ µ3 or µ1 ≥ µ2 ≥ µ3
vs. (2.1)
H1 : µ2 < min{µ1, µ3} or µ2 > max{µ1, µ3}.
Here, i indexes genotypes with i = 1 for one parent, i = 2 for the hybrid, and i = 3 for the
other parent. The response yij is the measure of a trait of interest for the jth replication
of genotype i. The parameter vector µ = (µ1, µ2, µ3)′ contains the genotype means.
The alternative hypothesis in (2.1) implies the existence of heterosis for the trait of
interest. More precisely, the alternative hypothesis indicates either low-parent heterosis
(hybrid mean lower than the lowest of the two parental means) or high-parent heterosis
(hybrid mean higher than the highest of the two parental means). Low-parent and high-
parent heterosis can be considered special cases of a third type of heterosis known as mid-
parent heterosis where the mean of the hybrid differs from the average of the two parental
means. Because mid-parent heterosis in general is not as interesting as the special cases of
low-parent and high-parent heterosis from a scientific, economic, and statistical standpoint,
we focus in this paper on the problem of detecting either low-parent or high-parent heterosis
and for simplicity use the term heterosis to mean low-parent or high-parent heterosis. With
this terminology, the null hypothesis in (2.1) is the “no heterosis” null hypothesis.
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The hypotheses in (2.1) may be written as
H0 : b′1µ ≥ 0, b′2µ ≥ 0 or b′1µ ≤ 0, b′2µ ≤ 0
vs. (2.2)
H1 : b′1µ > 0, b
′
2µ < 0 or b
′
1µ < 0, b
′
2µ > 0,
where b1 = (−1, 1, 0)′ and b2 = (0,−1, 1)′. The null hypothesis in (2.1) constrains µ to
a union of two closed, convex polyhedral cones in R3. The boundary of this region is
defined by the two intersecting planes {µ ∈ R3 : µ1 = µ2} = {µ ∈ R3 : b′1µ = 0} and
{µ ∈ R3 : µ2 = µ3} = {µ ∈ R3 : b′2µ = 0}. Panel (a) in Figure 2.1 shows a two-dimensional
projection of the null (unshaded) and the alternative (shaded) parameter spaces. The point
in the center of the figure corresponds to the line {µ ∈ R3 : µ1 = µ2 = µ3}, the intersection
of the two region-defining planes.
Robertson, Wright and Dykstra (1988) and Silvapulle and Sen (2005) describe a long
history of research on problems where either the null or the alternative hypothesis constrains
a parameter vector to a single cone. There is considerably less work on problems that involve
union-of-cones constraints. One notable exception is the problem of testing for qualitative
or cross-over interactions, which are of great importance in clinical trials. Gail and Simon
(1985) derived the asymptotic distribution of the likelihood ratio test (LRT) for qualitative
interactions, and Silvapulle (2001) derived the exact distribution for the LRT statistic for
the finite sample case. In order to obtain a test more powerful than the likelihood ratio
test, Zelterman (1990) showed how to expand the LRT rejection region without changing
the size of the test. Zelterman’s (1990) more powerful test is calculated using the constraint
that, for any parameters on the boundary of the null and alternative parameter spaces, the
uniformly more powerful test rejects the null hypothesis with probability equal to the size
α. Berger (1989) constructed a size-α uniformly more powerful test by adding a series of
cubic areas to the LRT rejection region for problems where the alternative parameter space
is a single acute-angled cone or a union of two acute-angled cones. For the case where the
alternative space is an obtuse-angled cone or a union of two obtuse-angled cones, Liu and
Berger (1995) showed how to expand the LRT rejection area by adding a spindle shaped
region without increasing the size of the test. Despite the theoretical advantages of these
uniformly more powerful tests, Perlman and Wu (1999) have criticized their development
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and questioned their value in practical data analysis.
In this paper, we develop tests of the null and alternative hypotheses defined in (2.1)
and (2.2). We begin by introducing a transformation that reduces our problem involving
three mean parameters to a two-dimensional problem. The details of this transformation
are provided in Section 2.2. We provide the LRTs for the cases of known and unknown
variance σ2 in Section 2.3. In Section 2.4, we present the Intersection-Union Test (IUT)
and show that it is uniformly less powerful than the LRT for testing the hypotheses in (2.1).
In Section 2.5, we discuss the possibility of constructing a test uniformly more powerful than
the LRT. We illustrate the application of our proposed LRT by testing for gene expression
heterosis in Section 2.6. Summary and conclusions are provided in Section 2.7.
2.2 The Transformation
The hypotheses in (2.1) involve the three mean parameters µ1, µ2 and µ3. However
based on the expression of the constraints in (2.2), only two dimensions are relevant to the
problem. Thus, we can develop a transformation that projects the testing problem onto a
two-dimensional space.
For the case of known σ2, consider the transformation X0 = (X1, X2, X3)′ = TY and
θ0 = (θ1, θ2, θ3)′ = Tµ, where Y =
(P
Y1j
n ,
P
Y2j
n ,
P
Y3j
n
)′
= (Y¯1·, Y¯2·, Y¯3·)′, and
T =
√
n
σ

− 1√
6
√
2√
3
− 1√
6
− 1√
2
0 1√
2
1√
3
1√
3
1√
3
 . (2.3)
Then X0 follows a three-dimensional normal distribution with mean θ0 = (θ1, θ2, θ3)′ and
variance matrix I3×3.
In the case that σ2 is unknown, the transformation becomes X0 = T (σˆ)Y , with σ in
(2.3) being replaced by the square root of the estimate σˆ2 = MSE =
P3
i=1
Pn
j=1(Yij−Y¯i·)2
3n−3 . In
this case, X0 follows Kshirsagar’s non-central multivariate t distribution with degrees of
freedom 3n− 3 and parameter θ0 (Kshirsagar, 1961) with joint pdf
fncmvt(x0) = exp
(
−1
2
θ0
′
θ0
)
Γ
(
3n
2
)
{(3n− 3)pi} 32 Γ(3n−32 )
·
(
1 +
x0
′
x0
3n− 3
)− 3n
2
·
∞∑
r=0
Γ
(
3n+r
2
)
r!Γ
(
3n
2
) ( √2x0′θ0√
3n− 3 + x0′x0
)r
.
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Figure 2.1: The null (unshaded) and alternative (shaded) parameter spaces in terms of µ
and θ
For each i ∈ {1, 2, 3}, Xi has a non-central t distribution with 3n − 3 degrees of freedom
and non-centrality parameter θi. Note that X1, X2 and X3 are not independent (Siotani,
1976; Kotz and Nadarajah, 2004). Define X to be (X1, X2)′ and θ to be (θ1, θ2)′.
The hypothesis in (2.2) can be stated in terms of the two parameters θ1 and θ2 as follows:
H0 : h′kθ ≤ 0 k = 1, 2
or h′kθ ≥ 0 k = 1, 2
vs. (2.4)
H1 : h′1θ > 0 and h
′
2θ < 0
or h′1θ < 0 and h
′
2θ > 0,
where h1 = (
√
3
2 ,
1
2)
′ and h2 = (−
√
3
2 ,
1
2)
′. Figure 2.1 shows a two-dimensional projection
of the null and alternative parameter spaces in terms of µ (a) and the parameter spaces in
terms of θ (b). In both panels, the unshaded area represents the null space, and the shaded
area is the alternative space. Both the null and alternative spaces are unions of two vertical
cones.
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2.3 The Likelihood Ratio Test
In this section, we will present the LRT for testing the hypotheses in (2.1) or, equiv-
alently, (2.4). We will separately discuss the cases when σ2 is known and unknown. A
detailed derivation of the LRT is provided in Section 2.8.1 of the appendix.
For the case when σ2 is known, the LRT rejects the null hypothesis if χ¯2 = n
P3
i=1(Y¯i·−µ˜i)2
σ2
is large, where µ˜ = (µ˜1, µ˜2, µ˜3)′ is the MLE of the parameters under the restriction that µ1,
µ2 and µ3 are either increasingly or decreasingly ordered (i.e., µ1 ≤ µ2 ≤ µ3 or µ1 ≥ µ2 ≥
µ3). If Y¯1· ≤ Y¯2· ≤ Y¯3· or Y¯1· ≥ Y¯2· ≥ Y¯3·, then µ˜i = Y¯i· and χ¯2 = 0. If Y¯2· is the smallest
group mean, then χ¯2 = n
(
Y¯2· −min(Y¯1·, Y¯3·)
)2
/2σ2. If Y¯2· is the largest group mean, then
χ¯2 = n
(
Y¯2· −max(Y¯1·, Y¯3·)
)2
/2σ2.
The size-α LRT rejects H0 if and only if χ¯2 ≥ χ21,2α, where χ21,2α is the upper 2α quantile
of a chi-square distribution with 1 degree of freedom (χ21).
Equivalently, we can express the rejection region in terms of X, as
RL =
{
x : −
√
3x1 + 2zα ≤ x2 ≤
√
3x1 − 2zα
}
∪
{
x :
√
3x1 + 2zα ≤ x2 ≤ −
√
3x1 − 2zα
}
, (2.5)
where zα is the upper α quantile of a standard normal distribution. The shaded area in
Figure 2.2 shows the LRT rejection region RL in the X coordinate system. RL is a union
of two cones. The faces of the two cones are parallel to h′kX = 0, k = 1, 2. The distance
between the two vertices is 4
√
3
3 zα.
For the case when σ2 is unknown, the LRT rejects the null if
F¯ =
n
∑3
i=1(Y¯i· − µ˜i)2
MSE
> F1,3n−3,2α,
where F1,3n−3,2α is the upper 2α quantile of F distribution with degree of freedom 1 and
3n− 3. The rejection region expressed in terms of X is,
RL(σˆ) =
{
x : −
√
3x1 + 2t3n−3,α ≤ x2 ≤
√
3x1 − 2t3n−3,α
}
∪
{
x :
√
3x1 + 2t3n−3,α ≤ x2 ≤ −
√
3x1 − 2t3n−3,α
}
, (2.6)
where t3n−3,α is the upper α quantile of a central t distribution with 3n − 3 degrees of
freedom.
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Figure 2.2: Rejection region (shaded) of the LRT
2.4 The Intersection-Union Test
Because the parameter space associated with the null hypothesis in (2.1) is a union of
the two cones ΘI = {µ : µ1 ≤ µ2 ≤ µ3} and ΘD = {µ : µ1 ≥ µ2 ≥ µ3}, it is natural to
consider an intersection-union test (IUT). The IUT was first described by Lehmann (1952),
and the name was coined by Gleser (1973). We will discuss the IUT in this section and
show that the LRT is more powerful than the IUT.
In our special case, a level-α IUT based on individual LRTs will reject H0 : µ ∈ ΘI ∪ΘD
in favor of H1 : µ ∈ ΘcI ∩ΘcD if and only if both the size-α LRT of
H0I : µ ∈ ΘI vs. H1I : µ ∈ ΘcI
and the size-α LRT of
H0D : µ ∈ ΘD vs. H1D : µ ∈ ΘcD
reject their null hypotheses.
When σ2 is unknown, the LRT statistic for testing H0I : µ ∈ ΘI vs. H1I : µ ∈ ΘcI is
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F¯ I = n
∑3
i=1(y¯i·−µ˜Ii )2/MSE, where µ˜I = (µ˜I1, µ˜I2, µ˜I3)′ is the MLE of µ under the restriction
µ1 ≤ µ2 ≤ µ3. The value of the statistic F¯ I is shown in the following equations:
F¯ I =

0, Y¯1· ≤ Y¯2· ≤ Y¯3·
n(Y¯1·−Y¯2·)2
2MSE , Y¯2· ≤ Y¯1· ≤ Y¯3· or
Y¯2· ≤ Y¯3· ≤ Y¯1· and Y¯1·+Y¯2·2 ≤ Y¯3·
n(Y¯2·−Y¯3·)2
2MSE , Y¯1· ≤ Y¯3· ≤ Y¯2· or
Y¯3· ≤ Y¯1· ≤ Y¯2· and Y¯1· ≤ Y¯2·+Y¯3·2
n
P3
i=1(Y¯i·− Y¯1·+Y¯2·+Y¯3·3 )2
MSE , Y¯3· ≤ Y¯2· ≤ Y¯1· or
Y¯2· ≤ Y¯3· ≤ Y¯1· and Y¯1·+Y¯2·2 > Y¯3·
Y¯3· ≤ Y¯1· ≤ Y¯2· and Y¯1· > Y¯2·+Y¯3·2
=

0, X2 ≥
√
3X1 · sign(X1)
(
√
3
2 X1 +
1
2X2)
2, 1√
3
X1 ≤ X2 < −
√
3X1, X1 < 0
(
√
3
2 X1 − 12X2)2, − 1√3X1 ≤ X2 <
√
3X1, X1 > 0
X21 +X
2
2 , X2 < − 1√3X1 · sign(X1).
For any c ≥ 0,
sup
µ∈ΘI
{P (F¯ I ≥ c|µ1, µ2, µ3) : µ1 ≤ µ2 ≤ µ3} (2.7)
= P (F¯ I ≥ c|µ1 = µ2 = µ3)
=
1
6
I(0 ≥ c) + 1
4
P
(
n(Y¯1· − Y¯2·)2
2MSE
≥ c
∣∣∣µ1 = µ2 = µ3)
+
1
4
P
(
n(Y¯2· − Y¯3·)2
2MSE
≥ c
∣∣∣µ1 = µ2 = µ3)
+
1
3
P
(
n
∑3
i=1
(
Y¯i· − Y¯1·+Y¯2·+Y¯3·3
)2
MSE
≥ c
∣∣∣µ1 = µ2 = µ3)
=
1
2
P (F1,3n−3 ≥ c) + 13P (2F2,3n−3 ≥ c).
Thus, the size-α LRT rejection region for testing H0I vs. H1I is RI = {Y : F¯ I ≥ cIU}
with
1
2
P (F1,3n−3 ≥ cIU ) + 13P (2F2,3n−3 ≥ cIU ) = α. (2.8)
Likewise, for H0D vs. H1D, the LRT test statistic and corresponding size-α rejection
region are F¯D = n
∑3
i=1(y¯i·− µ˜Di )2/MSE and RD = {Y : F¯D ≥ cIU}, where µ˜D1 , µ˜D2 , µ˜D3 are
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Figure 2.3: The LRT rejection regions for testing (a) H0I vs. H1I and (b) H0D vs. H1D
the MLEs of µ1, µ2, µ3 subject to the restriction µ1 ≥ µ2 ≥ µ3. The IUT rejection region is
RI ∩RD.
In Figure 2.3, the unshaded cone near the top of panel (a) is the null parameter space ΘI
projected onto the X coordinate system, and the shaded area is the projection of the LRT
rejection region RI onto this same coordinate system; the unshaded cone near the bottom
of panel (b) is the null parameter space ΘD projected onto a the X coordinate system, and
the shaded area is the corresponding projection of the LRT rejection region RD. Then the
IUT based on RI and RD rejects H0 with the rejection region RIU = RI ∩RD. By (2.8), it
is clear that cIU > F1,3n−3,2α. So the LRT is uniformly more powerful than the IUT.
In a more general case, if the null and alternative hypotheses can be expressed as
H0 : µ ∈ Θ0 = ∪Mm=1Θm vs. H1 : µ ∈ Θ1 = ∩Mm=1Θcm, with M ≥ 2. The level α IUT
is rejected if and only if all the M individual tests of H0m : µ ∈ Θm vs. H1m : µ ∈ Θcm are
rejected at level α. Let Λ(y) and R = {y : Λ(y) < c} be the test statistic and the size-α
LRT rejection region for H0 vs. H1. Also, let Λm(y) and Rm = {y : Λm(y) < cmα} be the
test statistic and the size-α LRT rejection region for H0m : µ ∈ Θm vs. H1m : µ ∈ Θcm,
m = 1, . . . ,M . Berger (1997) proved that R = ∩Mm=1Rm under the following conditions:
1. c1α = . . . = cMα, and
2. for some m0 ∈ {1, . . . ,M}, there exists a sequence of parameter points
{µQ, Q = 1, 2, . . .} ⊂ Θm0
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such that limQ→∞ PµQ(Y ∈ Rm0) = α and limQ→∞ PµQ(Y ∈ Rm) = 1 for all m ∈
{1, . . . ,M}\m0.
In the special case of testing for heterosis, the first condition of Berger’s theorem holds
because cIU is the common critical value for the size-α LRTs of both H0I vs. H1I and
H0D vs. H1D. However, the second condition does not hold. For both H0I vs. H1I and
H0D vs. H1D, the least favorable parameter set within each null parameter space is the
intersection of the two cones, i.e., ΘI ∩ ΘD = {µ ∈ R3 : µ1 = µ2 = µ3}. Thus, for any
µ ∈ ΘI \ {µ ∈ R3 : µ1 = µ2 = µ3}, P (F¯ I ≥ cIU |µ) < α. For any {µQ, Q = 1, 2, . . .} ⊂ ΘI
such that limQ→∞ PµQ(Y ∈ RI) = α, the parameter µQ must approach the set {µ ∈
R3 : µ1 = µ2 = µ3} as Q → ∞. By continuity of PµQ(Y ∈ RD) as a function of µQ,
limQ→∞ PµQ(Y ∈ RD) = α < 1. Reversing the roles of I and D and applying the same basic
argument shows that limQ→∞ PµQ(Y ∈ RD) = α implies limQ→∞ PµQ(Y ∈ RI) = α < 1.
Therefore, Berger’s condition 2 does not hold for our test for heterosis.
2.5 More Powerful Tests
Berger (1989), Zelterman (1990) and Liu and Berger (1995) constructed tests that are
uniformly more powerful than size-α LRTs for testing problems that share some similarities
with the problem we consider in this paper. The common feature of the testing problems
that makes it possible to construct tests uniformly more powerful than size-α likelihood
ratio tests were discussed by Perlman and Wu (1999). In particular, for our problem and
others considered previously, the least favorable null distribution is not attained at any
point in the null parameter space, and the level α is only approached asymptotically as the
parameter moves on the boundary of the null parameter space away from the intersection
of cones whose union is the null parameter space. Such a situation makes it possible to
expand the rejection region of the LRT near the intersection of cones while maintaining size
α. By such expansions, the rejection probabilities of Berger’s (1989), Zelterman’s (1990)
and Liu and Berger’s (1995) tests are larger than the rejection probability of size-α LRT
for any points in the alternative space. Thus, these new tests are uniformly more powerful
than the size-α LRT. In this section, we will discuss the situation in which the uniformly
more powerful tests are constructed, and discuss their applicability in real data analyses.
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2.5.1 Uniformly More Powerful Tests when the Alternative Parameter Space
is a Single Cone
Let T = (T1, . . . , Tp) be a p-dimensional (p ≥ 2) random variable such that T ∼ Np(ξ, I),
where ξ = (ξ1, . . . , ξp)′ is a p-dimensional unknown parameter. Berger (1989) constructed
a test uniformly more powerful than the LRT for the test of
H0(B) : b
(B)
k
′
ξ ≤ 0 for some k = 1, . . . ,K
vs.
H1(B) : b
(B)
k
′
ξ > 0 for all k = 1, . . . ,K,
for the case in which for each k = 1, . . . ,K there is a k0 ∈ {1, . . . ,K} such that b(B)k
′
b
(B)
k0
≤ 0.
Berger’s uniformly more powerful test was constructed by adding a series of diamond shaped
areas between the origin T = 0p and the vertex of the cone of the size-α LRT rejection
region. If K = 2, Berger’s (1989) hypotheses can be expressed as
H0(B) : b
(B)
1
′
ξ ≤ 0 or b(B)2
′
ξ ≤ 0
vs.
H1(B) : b
(B)
1
′
ξ > 0 and b(B)2
′
ξ > 0
with b(B)1
′
b
(B)
2 ≤ 0. In this case, the alternative parameter space is a cone with angle no
larger than 90 degrees, and the null parameter space is a union of the cone b(B)1
′
ξ ≤ 0 and
the cone b(B)2
′
ξ ≤ 0. Figure 2.4 shows the null and the alternative parameter spaces of
Berger’s (1989) test with K = 2 and b(B)1
′
b
(B)
2 < 0, where the alternative space is an acute
cone. Figure 2.5 shows the special case that b(B)1
′
b
(B)
2 = 0, in which case the alternative
space is a right angle cone.
Liu and Berger (1995) pointed out that Berger’s (1989) test is not a size-α test if
b
(B)
1
′
b
(B)
2 > 0, in which case the alternative parameter space is an obtuse cone (Figure
2.6). Liu and Berger (1995) constructed a uniformly more powerful test by adding a spindle
shaped rejection region to the size-α LRT rejection region. This test can be applied to cases
with alternative parameter spaces with any angles smaller than 180 degrees.
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H1(B)H0(B)
b1
(B)
b2
(B)
Figure 2.4: The Null (unshaded) and Alternative (shaded) Parameter Spaces for the Case
where the Alternative Parameter Space is an Acute Cone
H1(B)H0(B)
b1
(B)
b2
(B)
Figure 2.5: The Null (unshaded) and Alternative (shaded) Parameter Spaces for the Case
where the Alternative Parameter Space is a Right Angle Cone
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Figure 2.6: The Null (unshaded) and Alternative (shaded) Parameter Spaces for the Case
where the Alternative Parameter Space is an Obtuse Cone
2.5.2 Uniformly More Powerful Tests when the Alternative Parameter Space
is a Union of Two Cones
Berger (1989) also constructed a test that can be applied when the alternative parameter
space is a union of two vertical cones with angles no larger than 90 degrees. The null and
alternative hypotheses can be expressed as follows:
H0(B) : b
(B)
k
′
ξ ≤ 0 for some k = 1, . . . ,K
and b(B)k
′
ξ ≥ 0 for some k = 1, . . . ,K
vs. (2.9)
H1(B) : b
(B)
k
′
ξ > 0 for all k = 1, . . . ,K,
or b(B)k
′
ξ < 0 for all k = 1, . . . ,K.
with the condition that for each k = 1, . . . ,K there is a k0 ∈ {1, . . . ,K} such that
b
(B)
k
′
b
(B)
k0
≤ 0. Figure 2.7 shows the null and the alternative parameter spaces for one
case where K = 2.
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Figure 2.7: The Null (unshaded) and Alternative (shaded) Parameter Spaces for the Case
where the Alternative Parameter Space is a Union of Two Acute Cones
Zelterman (1990) constructed an “approximate” size-α test for
H0(Z) : ξ ≥ 0 for all k = 1, . . . ,K
and ξ ≤ 0 for all k = 1, . . . ,K
vs.
H1(Z) : ξ > 0 for some k = 1, . . . ,K,
and ξ < 0 for some k = 1, . . . ,K
by obtaining the boundary of the rejection region with the size of the test as close to α
as possible. Because the rejection region constructed using Zelterman’s technique contains
the size-α LRT rejection region, this test is also uniformly more powerful than the LRT. In
Section 2.8.2 in the Appendix, we utilize Zelterman’s strategy to construct an approximate
size-α test that is uniformly more powerful than our LRT of Section 2.3. However, because
the rejection region is approximated using numerical techniques, the size of the test using
Zelterman’s method may slightly exceed α.
2.5.3 Comments on the Uniformly More Powerful Tests
The null and the alternative hypotheses we considered in this paper are shown in (2.4),
with the alternative parameter space being a union of two obtuse cones. To our knowledge,
no tests have been constructed in an analytical way that are uniformly more powerful than
the size-α LRT when the alternative parameter space is a union of two obtuse cones. Even
if it is possible to construct a uniformly more powerful test in this case, it is questionable if
27
such a test would be “superior” to the LRT. First of all, all the uniformly more powerful tests
have been constructed under the condition that the variances are known. Without known
variances, the uniformly more powerful tests encounter various problems in the construction
procedures or in maintaining the test levels. Thus, in real data analyses when the variances
are not known, the uniformly more powerful test cannot be applied. Secondly, Perlman and
Wu (1999) pointed out that, because the LRT rejection region is a subset of the uniformly
more powerful tests, for any true parameters in the null parameter space, the probability
for the uniformly more powerful tests to reject the null hypothesis is greater than the LRT.
This means, the uniformly more powerful tests have larger Type-I error than the LRT for
any parameters in the null parameter space. Cohen, Gatsonis and Marden (1983) showed
that the LRT is the uniformly most powerful test among all monotone tests with level-α.
Laska and Meisner (1989) showed that because the new constructed tests are not monotone,
they might give testing results that are counterintuitive.
We use an example to illustrate Laska and Meisner’s (1989) point. Figure 2.8 shows
the uniformly more powerful test constructed by Berger (1989), for the hypothesis in (2.9).
The shaded area
⋃6
v=1Rv is Berger’s test rejection region, and R1 ∪ R6 is the size-α LRT
rejection region. We can see that there are several facts that are counterintuitive. First,
Berger’s test rejects the null hypothesis when the MLE of ξ (say ξˆ) lies in the red area.
However, the red area is actually a part of the null parameter space. Second, the LRT
statistic is smaller when ξˆ = a than when ξˆ = b. However, by using Berger’s test, the null
hypothesis is rejected when ξˆ = a but is not rejected when ξˆ = b. Both of these two facts
demonstrate that the uniformly more powerful test constructed using Berger’s strategy may
yield testing result that are counterintuitive.
In general, although the uniformly more powerful tests might of some theoretical interest,
we ultimately recommend the likelihood ratio test in practical applications.
2.6 An Example
Approximately 95% of U.S. maize is produced from hybrids (Swanson-Wagner, 2006).
One example of phenotypic heterosis in maize is the F1 hybrid offspring with parent inbred
lines B73 and Mo17. F1 has taller plants, shorter maturation time, and higher yields than
both its parents (Hallauer and Miranda, 1981). In this example, we compare the gene
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Figure 2.8: The Rejection Region (shaded) of Berger’s (1989) Test for the Alternative
Parameter Space being a Union of Two Acute Cones
expressions of B73, Mo17 and F1 using the LRT with unknown σ2 introduced in Section
2.3, the IUT discussed in Section 2.4, and the method employed by Swanson-Wagner et
al. (2006). The method used by Swanson-Wagner et al. (2006) first conducts the overall
F-test. Then for the genes that show significance in the overall test, a follow-up t-test is
carried out to detect genes with significant expression heterosis. The experiment described
in Swanson-Wagner (2006) has a randomized complete block design. So the estimate of
the MSE and its corresponding degrees of freedom need to be concordant with the design,
which is (the number of genotypes - 1) × (the number of blocks - 1). Other than that, the
procedures of our LRT and the IUT are not affected by the design.
Figure 2.9 shows some examples of genes with and without significant evidence of expres-
sion heterosis. The left panel gives six example genes with their estimated mean expression
values of the two inbred lines B73 and Mo17, and the hybrid F1 offspring, projected in a
two-dimensional sub-space of the µ parameter space. The left panel also gives the projec-
tions of the rejection regions of the LRT (shaded), the IUT (smaller cones with boundaries
parallel to the boundary of the LRT), and the overall F-test (outside of the circle). The
right panel gives box-plots of the genotype-specific expression distributions for these six
genes.
Gene A and gene E are identified by the LRT with low-parent heterosis, where the
mean gene expression of F1 smaller than the mean gene expressions of either B73 or Mo17.
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Figure 2.9: (a) A projection of estimated means for genes A through F, along with rejection
regions of the overall F-test, the IUT, and LRT; (b) Boxplots of normalized expression
distributions by gene and genotype.
Gene B and gene F are identified by the LRT with high-parent heterosis, where the mean
gene expression of F1 greater than the mean gene expressions of either B73 or Mo17. The
IUT does not identify genes B, E, or F with significant heterosis. Gene C and gene D are
two genes without signficant evidence of heterosis. The mean expression values for gene C
follow the pattern B73 < F1 < Mo17, and the mean expression values for gene D follow the
pattern Mo17 < F1 < B73. The estimated means of standardized expressions for gene A
through F are provided in the first three columns of Table 2.1, and the p-values from tests
for evidence of gene expression heterosis using the size-α LRT and the IUT are also given
in this table (the fourth column and the fifth column).
Means P-values
Gene B73 F1 Mo17 LRT IUT F
A -0.657 -1.371 -0.651 1.098× 10−4 4.115× 10−4 1.947× 10−4
B 2.291 2.472 2.295 0.022 0.064 0.065
C 1.305 1.560 1.600 0.5 0.833 0.165
D 0.292 0.164 -0.098 0.5 0.833 0.007
E -1.007 -1.140 -1.007 0.032 0.091 0.101
F -0.152 0.067 -0.564 0.040 0.109 0.0001
Table 2.1: Normalized estimated means for genes A through F, and comparisons of p-values
using LRT, IUT and overall F-test.
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The null and alternative hypotheses in the first step test of Swanson-Wagner et al.
(2006) approach are µ1 = µ2 = µ3 and µi’s not all equal, respectively. The preliminary test
rejects the null hypothesis if Ftest =
P3
i=1 n(Y¯i·−Y¯··)2/(3−1)
MSE ≥ F2,18,α. In terms of X, the test
rejects the null if X21 +X
2
2 ≥ 2F2,18,α. The circle on the left panel in Figure 2.9 shows the
boundary of the overall F-test rejection region. Gene expression means that project within
the circle will show no significant difference among the genotypes, so no further study will
be done on these genes. We can see that there are two areas inside both the circle and the
shaded region. Data with means that project within the overlapping areas will be identified
as having significant evidence of heterosis by the LRT, but will fail to be rejected by the
overall F-test. Thus, pre-screening with the overall F test can fail to identify heterotic traits
that the LRT can detect. For example, gene B and gene E in Figure 2.9 are not rejected
by the overall test. On the other hand, gene D does have a significant overall F-test even
though it shows no evidence of heterosis. The p-values using the overall F-test are listed in
the last column of Table 2.1.
2.7 Summary and Conclusions
In this paper, we considered a hypothesis that is motivated by the problem of detecting
heterosis for a trait of interest. The null parameter space of no heterosis is a union of two
convex cones. The alternative parameter space is the complement of the null and is also
a union of two convex cones. We derived the size-α LRT with and without known sample
variance σ2. Because the null parameter space is a union of two cones, we also considered
the intersection-union test (IUT). We derived the testing procedure of the IUT, compared
it with the LRT, and drew the conclusion that the LRT is uniformly more powerful than
the IUT for detecting heterosis.
We also found that, for any parameters in the null space, the type-I error for the size-α
LRT is smaller than α, and the least favorable distribution is only achieved in the limiting
case as the parameter moves on the boundary of the null space away from the intersection
point of the null cones. We discuss the situations in which tests that are uniformly more
powerful than the LRT can be constructed. We also derived an approximate test that is
uniformly more powerful than the size-α LRT, by using the strategy proposed by Zelterman
(1990), for the case that σ2 is known. However, there are concerns about such uniformly
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more powerful tests in practical data analysis.
In the example of detecting heterosis using maize gene expression data, we compared
the result of the LRT, the IUT and the method by Swanson-Wagner (2006). We found
examples of genes that showed significant evidence of heterosis at the 0.05 level with the
LRT but not with the IUT or the methods used by Swanson-Wagner et al. (2006). Although
uniformly more powerful tests shows larger detection power than the LRT in theory, they
are not applicable in the real data analyses. In general, we recommend the use of the LRT
in practical data analyses.
2.8 Appendix
2.8.1 Derivation of the LRT
For the case when σ2 is known, the ratio of the maximized likelihoods under H0 and
H0 ∪H1 is
Λ = e−
P3
i=1
Pn
j=1((Yij−µ˜i)2−(Yij−Y¯i·)2)
2σ2 ,
where Y¯i· =
Pn
j=1 Yij
n (i = 1, 2, 3), and µ˜ = (µ˜1, µ˜2, µ˜3)
′ is the MLE of the parameters with
the restriction that µ1 ≤ µ2 ≤ µ3 or µ1 ≥ µ2 ≥ µ3. Equivalently, the LRT rejects the null
hypothesis if χ¯2 = n
P3
i=1(Y¯i·−µ˜i)2
σ2
is too large. We evaluate χ¯2 as follows:
χ¯2 =

0, if min(Y¯1·, Y¯3·) ≤ Y¯2· ≤ max(Y¯1·, Y¯3·);
n
(
Y¯2· −min(Y¯1·, Y¯3·)
)2
/2σ2, if Y¯2· < min(Y¯1·, Y¯3·);
n
(
Y¯2· −max(Y¯1·, Y¯3·)
)2
/2σ2, if Y¯2· > max(Y¯1·, Y¯3·).
The size-α LRT is to reject χ¯2 ≥ c with some relevant values of c, such that
sup
{
P (χ¯2 ≥ c|µ1, µ2, µ3) : µ1 ≤ µ2 ≤ µ3 or µ1 ≥ µ2 ≥ µ3
}
= α. (2.10)
Expressing χ¯2 using X, we have
χ¯2 =

0, if −X2 · sign(X2) ≤
√
3X1 ≤ X2 · sign(X2);(√
3
2 X1 +
1
2X2 · sign(X2)
)2
, if
√
3X1 < −X2 · sign(X2);(√
3
2 X1 − 12X2 · sign(X2)
)2
, if
√
3X1 > X2 · sign(X2).
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With some relevant values of c, the size-α LRT rejection region can be expressed as
RL = {X : −
√
3X1 + 2c ≤ X2 ≤
√
3X1 − 2c}
∪ {x :
√
3X1 + 2c ≤ X2 ≤ −
√
3X1 − 2c}, (2.11)
such that
sup
θ∈H0
{
P (X ∈ RL)
}
= α. (2.12)
By Sasabuchi (1980), for the case when the null parameter space is a union of two vertical
cones, and the alternative parameter space being the complement of the null parameter
space is also a union of two vertical cones, the least favorable cases in the null parameter
space can be determined only when each cone of the alternative parameter space is an
acute cone. In this paper, we prove that, with some relevant values of c not too small, the
supremum of the left side of (2.10) achieves with any one of the following four cases:
θ1 → −∞ and h′1θ = 0,
or θ1 →∞ and h′1θ = 0,
or θ1 → −∞ and h′2θ = 0,
or θ1 →∞ and h′2θ = 0. (2.13)
Proof. First we prove that for any θ = (θ1, θ2)′ ∈ H0, there exists a θ1 on the
boundary of the null parameter space, i.e., θ1 ∈ H00 , {θ : h′1θ = 0 or h′2θ = 0}, such that
Pθ(X ∈ RL) ≤ Pθ1(X ∈ RL). So the least favorable cases only happen on the boundary of
the null parameter space.
For random variable X = (X1, X2)′ with mean θ = (θ1, θ2)′, we have if (x1, x2)′ ∈ RL,
then (x1,−x2)′ ∈ RL. Consider the transformation
 T1
T2
 = ∆
 X1
X2
 with ∆ =

√
2
2 −
√
2
2
√
2
2
√
2
2
. Then the mean for (T1, T2)′ is η = (η1, η2)′ = ∆(θ1, θ2)′. The LRT
rejection region in the (T1, T2)′ coordinate system is ∆RL =
{
t : ∆−1t ∈ RL
}
. We have
that if (t1, t2)′ ∈ ∆RL, then (t2, t1)′ ∈ ∆RL. So ∆RL satisfies:
For any (t11, t12)′ ∈ ∆RL, if (t21, t22)′ is majorized by (t11, t12)′, then we have (t21, t22)′ ∈
∆RL. Here (t21, t22)′ is majorized by (t11, t12)′ means max{t21, t22} ≤ max{t11, t12}, and
t11 + t12 = t21 + t22, which is denoted as (t21, t22)′ ≺ (t11, t12)′.
33
Also, for any (t21, t22)′ and (t11, t12)′, if (t21, t22)′ ≺ (t11, t12)′, then φ(t21)φ(t22) ≥
φ(t11)φ(t12), i.e., φ(t1)φ(t2) is Schur-Concave function of (t1, t2)′. By Theorem 2.1 of Mar-
shall and Olkin (1974),
∫
∆RL+η
φ(t1)φ(t2) dt1 dt2 is a Schur-Concave function of η, where∫
∆RL+η
φ(t1)φ(t2) dt1 dt2 = P(0,0)′
(
(T1, T2)′ ∈ ∆RL + η
)
= Pη
(
(T1, T2)′ ∈ ∆RL
)
.
Consequently, for any θ ∈ H0 and its corresponding η = ∆θ, there exists an
η1 =

(
√
2−√6
2 ,
√
2+
√
6
2 )
′θ1 if θ1θ2 ≥ 0,
(
√
2+
√
6
2 ,
√
2−√6
2 )
′θ1 if θ1θ2 < 0,
(2.14)
with corresponding θ1 = (θ11, θ12)′ = ∆−1η1 ∈ H00 , such that η1 ≺ η and∫
∆RL+η
φ(t1)φ(t2) dt1 dt2 ≤
∫
∆RL+η1
φ(t1)φ(t2) dt1 dt2.
So we have
Pθ
(
(X1, X2)′ ∈ RL
)
=
∫
RL+θ
φ(x1)φ(x2) dx1 dx2
=
∫
∆RL+η
φ(t1)φ(t2) dt1 dt2
≤
∫
∆RL+η1
φ(t1)φ(t2) dt1 dt2
=
∫
RL+θ1
φ(x1)φ(x2) dx1 dx2
= Pθ1
(
(X1, X2)′ ∈ RL
)
,
which means the least favorable cases only happen on the boundary of the null parameter
space, H00 .
Now we are going to prove that under certain conditions of c, the least favorable cases
in H00 are the cases in (2.13).
sup
θ∈H00
{
P (X ∈ RL)
}
= sup
θ∈H00
{
P
(√3
2
X1 +
1
2
X2 ≥ c,
√
3
2
X1 − 12X2 ≥ c
)
+P
(√3
2
X1 +
1
2
X2 ≤ −c,
√
3
2
X1 − 12X2 ≤ −c
)}
.
Let W1 = (
√
3
2 ,
1
2)(X − θ), W2 = (
√
3
2 ,−12)(X − θ). Then W = (W1,W2)′ ∼ N2(0,R),
34
where R =
 1 12
1
2 1
. So
sup
θ∈H00
{
P (X ∈ RL)
}
= sup
θ∈H00
{
P
(
W1 ≥ c− (
√
3
2
,
1
2
)θ, W2 ≥ c− (
√
3
2
,−1
2
)θ
)
+P
(
W1 ≤ −c− (
√
3
2
,
1
2
)θ, W2 ≤ −c− (
√
3
2
,−1
2
)θ
)}
.
Let τ1 = (
√
3
2 ,
1
2)θ, τ1 = (
√
3
2 ,−12)θ, and
ζ(τ1, τ2; c)
= P (W1 ≥ c− τ1, W2 ≥ c− τ2) + P (W1 ≤ −c− τ1, W2 ≤ −c− τ2)
=
∫ ∞
c−τ1
∫ ∞
c−τ2
n0,R(w1, w2) dw1 dw2 +
∫ ∞
c+τ1
∫ ∞
c+τ2
n0,R(w1, w2) dw1 dw2,
where n0,R(w1, w2) denotes the two-dimensional multivariate normal density function with
mean 0 = (0, 0)′ and variance matrix R. Notice that τ1 = 0 is equivalent to h′1θ = 0, τ2 = 0
is equivalent to h′2θ = 0. Taking derivative of ζ(τ1, τ2; c) with respect to τ1 and evaluating
it at τ2 = 0, we get
d
dτ1
ζ(τ1, τ2; c)
∣∣∣∣
τ2=0
=
∫ ∞
c
n0,R(c− τ1, w2)− n0,R(c+ τ1, w2) dw2
=
1
2pi|R|1/2
∫ ∞
c
exp
(
− 2
3
(c− τ1)2 + 23(c− τ1)w2 −
2
3
w22
)
− exp
(
− 2
3
(c+ τ1)2 +
2
3
(c+ τ1)w2 − 23w
2
2
)
dw2. (2.15)
Consider
(
− 2
3
(c− τ1)2 + 23(c− τ1)w2 −
2
3
w22
)
−
(
− 2
3
(c+ τ1)2 +
2
3
(c+ τ1)w2 − 23w
2
2
)
=
4
3
τ1(2c− w2),
if τ1 > 0, we have
∫ 2c
c n0,R(c− τ1, w2)−n0,R(c+ τ1, w2) du2 > 0, and
∫∞
2c n0,R(c− τ1, w2)−
n0,R(c + τ1, w2) dw2 ≤ 0; if τ1 < 0,
∫ 2c
c n0,R(c − τ1, w2) − n0,R(c + τ1, w2) dw2 < 0, and∫∞
2c n0,R(c− τ1, w2)− n0,R(c+ τ1, w2) dw2 ≥ 0.
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We have the conclusion that under the condition that c is not too small, for τ1 > 0,
d
dτ1
ζ(τ1, τ2; c)
∣∣∣∣
τ2=0
> 0,
and f(τ1, τ2; c) is increasing as τ1 increasing; for τ1 < 0,
d
dτ1
ζ(τ1, τ2; c)
∣∣∣∣
τ2=0
< 0,
and ζ(τ1, τ2; c) is increasing as τ1 decreasing. So we proved that with c not too small, the
maximum value of the power function attains at θ1 →∞, h′2θ = 0, or θ1 → −∞, h′2θ = 0.
Similarly, by taking derivative of ζ(τ1, τ2; c) with respect to τ2 and evaluating it at
τ1 = 0, we can prove that with the same condition of c, the maximum value of the power
function also attains at θ1 →∞, h′1θ = 0, or θ1 → −∞, h′1θ = 0.
Equivalently, with the same condition on c > 0, the least favorable cases in the null
parameter space is expressed in terms of Y and µ are
µ1 → −∞ and µ2 = µ3,
or µ1 →∞ and µ2 = µ3,
or µ3 → −∞ and µ1 = µ2,
or µ3 →∞ and µ1 = µ2. (2.16)
So we have
sup
{
P (χ¯2 ≥ c|µ1, µ2, µ3) : µ1 ≤ µ2 ≤ µ3 or µ1 ≥ µ2 ≥ µ3
}
= lim
µ1→−∞
P (χ¯2 ≥ c|µ1, µ2 = µ3) = lim
µ1→∞
P (χ¯2 ≥ c|µ1, µ2 = µ3)
= lim
µ3→−∞
P (χ¯2 ≥ c|µ1 = µ2, µ3) = lim
µ3→∞
P (χ¯2 ≥ c|µ1 = µ2, µ3). (2.17)
Taking limµ1→−∞ P (χ¯2 ≥ c|µ1, µ2 = µ3) as an example,
sup
{
P (χ¯2 ≥ c|µ1, µ2, µ3) : µ1 ≤ µ2 ≤ µ3 or µ1 ≥ µ2 ≥ µ3
}
= lim
µ1→−∞
P (χ¯2 ≥ c|µ1, µ2 = µ3)
=
(
lim
µ1→−∞
P (Y¯1· < Y¯2· < Y¯3·|µ1, µ2 = µ3)
)
I{0≥c}
+
(
lim
µ1→−∞
P (Y¯1· < Y¯3· < Y¯2·|µ1, µ2 = µ3)
)
P
(
n(Y¯2· − Y¯3·)2
2σ2
≥ c
)
=
1
2
I{0≥c} +
1
2
P (χ21 ≥ c),
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we have c = χ21,2α, which is the upper 2α quantile of χ
2
1. So the size-α LRT with known σ
2
is to reject H0 with χ¯2 ≥ χ21,2α. Or in terms of X and θ, the size-α LRT rejection region is
RL = {x : −
√
3x1 + 2zα ≤ x2 ≤
√
3x1 − 2zα}
∪ {x :
√
3x1 + 2zα ≤ x2 ≤ −
√
3x1 − 2zα}.
For the case when σ2 is unknown,
Λ =
1
(2piσ˜2)
3n
2
exp(−
P3
i=1
Pn
j=1(Yij−µ˜i)2
2σ˜2
)
1
(2piσˆ2)
3n
2
exp(−
P3
i=1
Pn
j=1(Yij−Y¯i.)2
2σˆ2
)
,
where σˆ2 =
∑3
i=1
∑n
j=1(Yij − Y¯i·)2/(3n− 3) = MSE, σ˜2 =
∑3
i=1
∑n
j=1(Yij − µ˜i)2/(3n− 3).
So
Λ =
(∑3
i=1
∑n
j=1(Yij − Y¯i·)2∑3
i=1
∑n
j=1(Yij − µ˜i)2
) 3n
2
=
( ∑3
i=1
∑n
j=1(Yij − Y¯i·)2∑3
i=1
∑n
j=1(Yij − Y¯i·)2 + n
∑3
i=1(Y¯i· − µ˜i)2
) 3n
2
=
(
(3n− 3)MSE
(3n− 3)MSE + n∑3i=1(Y¯i· − µ˜i)2
) 3n
2
.
H0 is rejected when Λ is small, which means rejecting if
F¯ =
n
∑3
i=1(Y¯i· − µ˜i)2
MSE
is too large.
F¯ =

0, if min(Y¯1·, Y¯3·) ≤ Y¯2· ≤ max(Y¯1·, Y¯3·);
n
(
Y¯2· −min(Y¯1·, Y¯3·)
)2
/(2MSE), if Y¯2· < min(Y¯1·, Y¯3·);
n
(
Y¯2· −max(Y¯1·, Y¯3·)
)2
/(2MSE), if Y¯2· > max(Y¯1·, Y¯3·).
In order to generalize to the case with σ2 unknown that, for some values of c not too
small, the least favorable cases in the null parameter space is (2.13) in terms of X and θ,
first we prove the least favorable cases only happen on the boundary of the null parameter
space, H00 . Here we only need to prove that the central multivariate t distribution
fcmvt((t1, t2)′) =
Γ
(
3n−1
2
)
(3n− 3)piΓ (3n−32 )
(
1 +
t21 + t
2
2
3n− 3
)− 3n−1
2
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is a Schur-Concave function of (t1, t2)′. This is true because, if (t21, t22)′ ≺ (t11, t12)′ then
t221 + t
2
22 ≤ t211 + t212. We have fcmvt((t11, t12)′) ≤ fcmvt((t21, t22)′), i.e., fcmvt((t1, t2)′)
is a Schur-Concave function of (t1, t2)′. By Theorem 2.1 of Marshall and Oklin (1974),∫
∆RL+η
fcmvt((t1, t2)′)dt1dt2 is a Schur-Concave function of (t1, t2)′. By similar process, for
any θ ∈ H0, there exists an θ1 ∈ H00 , and Pθ((X1, X2)′ ∈ RL) ≤ Pθ1((X1, X2)′ ∈ RL). So
when σ2 is unknown, the least favorable cases also only happen on the boundary of the null
parameter space, H00 .
The next step is to prove with the same condition of c (where c not too small), the least
favorable cases in H00 are the cases in (2.13). With the transformation W1 = (
√
3
2 ,
1
2)(X−θ)
and W2 = (
√
3
2 ,−12)(X − θ), W = (W1,W2)′ ∼ cmvt3n−3(0,R) with probability function
fcmvt3n−3(0,R)(w1, w2) =
√
3
2 Γ
(
3n−1
2
)
(3n− 3)piΓ (3n−32 )
(
1 +
(
√
3
3 w1 +
√
3
3 w2)
2 + (w1 − w2)2
3n− 3
)− 3n−1
2
.
So
ζσˆ(τ1, τ2; c)
= P (W1 ≥ c− τ1, W2 ≥ c− τ2) + P (W1 ≤ −c− τ1, W2 ≤ −c− τ2)
=
∫ ∞
c−τ1
∫ ∞
c−τ2
fcmvt3n−3(0,R)(w1, w2) dw1 dw2 +
∫ ∞
c+τ1
∫ ∞
c+τ2
fcmvt3n−3(0,R)(w1, w2) dw1 dw2.
d
dτ1
ζσˆ(τ1, τ2; c)
∣∣∣∣
τ2=0
=
∫ ∞
c
fcmvt3n−3(0,R)(c− τ1, w2)− fcmvt3n−3(0,R)(c+ τ1, w2) dw2
=
√
3
2 Γ
(
3n−1
2
)
(3n− 3)piΓ (3n−32 )
∫ ∞
c
(
1 +
(c− τ1 + w2)2/3 + (c− τ1 − w2)2
3n− 3
)− 3n−1
2
−
(
1 +
(c+ τ1 + w2)2/3 + (c+ τ1 − w2)2
3n− 3
)− 3n−1
2
dw2.
Consider (c− τ1 +w2)2/3 + (c− τ1−w2)2− (c+ τ1 +w2)2/3 + (c+ τ1−w2)2 = 83τ1(w2−2c).
So we draw the conclusion that with the same condition of c that c is not too small, for
τ1 > 0, ddτ1 ζσˆ(τ1, τ2; c)
∣∣
τ2=0
> 0; for τ1 < 0, ddτ1 ζσˆ(τ1, τ2; c)
∣∣
τ2=0
< 0. And the least favorable
cases in the null parameter space is (2.13) in terms of θ or (2.16) in terms of µ.
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Consequently,
sup
{
P (F¯ ≥ c|µ1, µ2, µ3) : µ1 ≤ µ2 ≤ µ3 or µ1 ≥ µ2 ≥ µ3
}
= lim
µ1→−∞
P (F¯ ≥ c|µ1, µ2 = µ3) = lim
µ1→∞
P (F¯ ≥ c|µ1, µ2 = µ3)
= lim
µ3→−∞
P (F¯ ≥ c|µ1 = µ2, µ3) = lim
µ3→∞
P (F¯ ≥ c|µ1 = µ2, µ3)
=
1
2
I{0≥c} +
1
2
P (F1,3n−3 ≥ c).
So the critical value for the size-α LRT is F1,3n−3,2α, the upper 2α quantile of F distribution
with degree of freedom 1 and 3n− 3. Expressing the rejection region in terms of X,
RL(σˆ) = {x : −
√
3x1 + 2t3n−3,α ≤ x2 ≤
√
3x1 − 2t3n−3,α}
∪ {x :
√
3x1 + 2t3n−3,α ≤ x2 ≤ −
√
3x1 − 2t3n−3,α}.
2.8.2 Application of Zelterman’s Test on Our Testing Problem
We construct the uniformly more powerful test to our testing problem, following Zelter-
man’s strategy. The main idea of Zelterman’s method is to enlarge the size-α LRT rejection
region with the constraint that the rejection probability at the boundary of the new test
rejection region strictly equals α. Denote d(x) as the rejection rule for H0 vs. H1, i.e.,
d(x) = 1 if H0 is rejected with observation x and d(x) = 0 otherwise. The power function
is denoted as Pθ(d(X) = 1). Suppose q(x1) is a non-negative function symmetric with
respect to X1, which defines the rejection region as follows,
d(x) =

1, if |x2| ≤ q(x1),
0, otherwise,
(2.18)
where q(x1) ≥ 0 and q(−x1) = q(x1).
By Zelterman’s construction, the expression of q(x1) is as follows
q(x1) =

Φ−1
(∑∞
j=0 c2jH2j(x1)
)
, if |x1| < x1α,
|x1| − 21/2Φ−1(1− α), if |x1| ≥ x1α,
(2.19)
where c2j (j = 1, 2, . . .) are the coefficients, and Hn(x1) are the probabilists’ Hermite
polynomials defined as follows:( ∂
∂x1
)n
φ(x1) = (−1)nHn(x1)φ(x1), n = 1, 2, . . . , and H0(x1) = 1.
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o x1α−x1α 2zα
3
−
2zα
3
Figure 2.10: A schematic plot of a rejection region using Zelterman’s method
By defining q(x1) using this piecewise function, the new test coincides with the LRT when x1
is greater than x1α. The values of x1α and all c2j (j = 1, 2, . . .) are determined numerically
by the contraint ∫ ∞
−∞
|P(θ1,√3θ1)′(d(X) = 1)− α| dθ1 = 0, (2.20)
where
Pθ(d(X) = 1)
=
∫ ∞
−∞
∫ q(x1)
−q(x1)
φ(x1 − θ1)φ(x2 − θ2) dx2 dx1
=
∫ ∞
−∞
φ(x1 − θ1)
(
Φ(q(x1)− θ2) + Φ(q(x1) + θ2)
)
dx1 − 1. (2.21)
Figure 2.10 is a schematic plot of a rejection region for our problem derived using
Zelterman’s method, analogous to the plot shown in Zelterman’s (1990) paper.
In the case where σ2 is unknown, the values of x1α and all c2j , j = 1, 2, . . . are also
determined by the constraint (2.20), while the power function in (2.21) needs to be cal-
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culated using the non-central multivariate t distribution density function, i.e., Pθ(d(X) =
1) =
∫ ∫
d(X)
∫∞
−∞ fncmvt(x
0) dx3dx1dx2.
2.8.2.1 Notes on Zelterman’s Test
There are some notes worth to be made here. First, all the unknown parameters are
determined by the constraint in (2.20) with the numeric solutions. No analytical solution
can be made here, which is not easy in real data analyses. It is even more complicated
when σ2 is unknown σ2 due to the dependency among the variables X1, X2 and X3.
The more powerful test rejection region is a union of two areas: the LRT rejection region,
which is a union of two cones, and the expanded area between the two cones. By Liu and
Berger (1995), if this expanded area touches the LRT rejection region at more than the
vertices of the LRT rejection region cones, then the size of the new test will be greater than
α. So for test discussed in this paper, x1α should be no larger than 2
√
3
3 zα with known σ
2;
and for the testing problem in Zelterman’s (1990) paper, x1α should be be no larger than
√
2zα. However, this value shown on Zelterman’s paper is x1α = 2.7689 at α = 0.05, which
is greater than
√
2z0.05. This contradiction might be caused by a mistake in the derivation
in Zelterman’s paper, which will be discussed in the following paragraph.
We use the notation of Zelterman’s paper within this paragraph, for the sake of the
consistency. We will discuss the equation (2.8) in Zelterman’s paper, where∫ ∞
−∞
h2(r)φ(r)Φ(q(r)) dr =
1
2
α.
By Zelterman’s statement, this is derived from the equations in Zelterman’s paper that,∫∞
−∞Φ(q(r))φ(r) dr =
1
2(α+ 1), and that
∫∞
−∞
∫∞
−∞ d(x)x1x2φ(x1)φ(x2) dx1 dx2 = −α with
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s = 1√
2
(x1 + x2) and r = 1√2(x1 − x2). We will see that this is not correct:
−α =
∫ ∞
−∞
∫ ∞
−∞
d(x)x1x2φ(x1)φ(x2) dx1 dx2
=
∫ ∞
−∞
∫ q(r)
−q(r)
1
2
(s2 − r2)φ(s)φ(r) ds dr
=
∫ ∞
−∞
1
2
φ(r)
∫ q(r)
−q(r)
(s2 − r2)φ(s) ds dr
=
1
2
∫ ∞
−∞
φ(r)
(∫ q(r)
−q(r)
s2φ(s) ds− 2r2Φ(q(r)) + r2
)
dr
=
∫ ∞
−∞
φ(r)
∫ q(r)
0
s2φ(s) ds dr −
∫ ∞
−∞
r2φ(r)Φ(q(r)) dr +
1
2
=
∫ ∞
−∞
φ(r)
∫ q(r)
0
s2φ(s) ds dr −
∫ ∞
−∞
h2(r)φ(r)Φ(q(r)) dr − 12(α+ 1) +
1
2
,
=
∫ ∞
−∞
φ(r)
∫ q(r)
0
s2φ(s) ds dr −
∫ ∞
−∞
h2(r)φ(r)Φ(q(r)) dr − 12α,
which means ∫ ∞
−∞
h2(x)φ(x)Φ(q(r)) dr =
∫ ∞
−∞
φ(r)
∫ q(r)
0
s2φ(s) ds dr +
1
2
α
with
∫∞
−∞ φ(r)
∫ q(r)
0 s
2φ(s) ds dr ≥ 0. ∫∞−∞ φ(r) ∫ q(r)0 s2φ(s) ds dr = 0 if and only if q(r) = 0
except sets with measure zero, so
∫∞
−∞ h2(r)φ(r)Φ(q(r)) dr >
1
2α with probability 1.
This mistake in Zelterman’s paper results in the incorrect values for x1α and c2j (j =
1, 2, . . .) obtained in Zelterman’s paper.
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CHAPTER 3. Testing for Monotonic Changes in Multivariate Gene
Expression Distributions
Abstract
We develop four procedures that can be used to test for association between a response
vector and a treatment factor whose levels are quantitative or ordinal. The testing proce-
dures are applied to the problem of identifying gene sets comprised of genes whose expression
levels tend to change monotonically with the level of treatment. The proposed procedures
are able to deal with small sample sizes and high-dimensional distributions, and simulation
studies demonstrate that the proposed methods have higher power for detecting monotonic
associations than traditional testing procedures that spread power more evenly over the
whole alternative parameter space.
KEY WORDS: Gene Sets; Large p, Small n; Monotonic Alternative Hypothesis; Permuta-
tion Test; Order-restricted Statistical Inference.
3.1 Introduction
3.1.1 Background and Motivation
Many experimental factors are quantitative or ordinal and thus have levels that can be
naturally ordered. As the level of such a factor is increased, it is often reasonable to assume
that a mean response will change monotonically if the factor and response are associated
with each other. For example, within certain dose ranges, as the dose of a drug is increased,
the plasma concentration of the drug increases, and the effect or side effects of the drug
may be strengthened. To study the molecular genetic mechanisms underlying phenomena
like dose-response relationships, researchers measure the expression of genes in response
to varying levels of quantitative or ordinal treatment factors. In these studies, finding
genes with monotonic changes in mean expression is of great interest. To increase power
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for detecting such genes, we propose four statistical tests that focus power on monotonic
departures from mean equality. We compare these four tests to three other standard testing
approaches that spread power more uniformly over the alternative parameter space.
The testing procedures that we propose are useful for detecting association between a
quantitative or ordinal factor and a single response variable. However, in gene expression
studies, we must deal simultaneously with thousands of response variables corresponding to
the expression levels of thousands of genes. To improve interpretability and to increase bio-
logical understanding, genes are often grouped into sets based on information obtained from
past research. Gene Ontology (GO) is one database that provides biological annotations
for genes, based on the knowledge that some genes are associated with each other in the
same cellular component or collaborate together to implement biological processes or com-
plete molecular functions (Ashburner, el al., 2000). Each GO category contains from under
10 to thousands of genes. Thus, in addition to considering tests of association between a
quantitative or ordinal factor and a single response variable, we also develop methods for
finding sets of genes (as defined by GO, for example) with expression levels that tend to be
monotonically associated with a quantitative or ordinal treatment factor.
3.1.2 A Formal Description of the Problem of Interest
The problem discussed in this paper can be described as follows. For i = 1, . . . , T
and j = 1, . . . , ni, let Yij = (Yij1, . . . , YijG)′ denote the jth replication under the ith
treatment of an expression vector corresponding to G genes in a gene set of interest. Here
Yijg represents the expression associated with treatment i, replication j, and gene g in the
gene set. We assume that all the ni replicates under the ith treatment share one common
multivariate distribution Fi, i.e.;
Yi1, Yi2, . . . , Yini∼Fi, for i = 1, . . . , T.
Furthermore, we assume that all N ≡∑Ti=1 ni random vectors are independent and that
E(Yij) = (µi1, . . . , µiG)′, i = 1, . . . , T , j = 1, . . . , ni.
We wish to test
H0 : F1 = . . . = FT ,
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vs. the alternative that H0 does not hold. We are especially interested in detecting de-
partures from H0 in which the means µ1g, . . . , µTg tend to change in a monotonic manner
across the ordered levels of the treatment factor for one or more genes g ∈ {1, . . . , G}. Thus,
we wish to develop testing procedures with enhanced power for detecting departures from
H0 when a gene set contains genes whose mean expression levels change monotonically with
treatment.
3.1.3 Previous Studies
There is a long history of research on univariate testing problems involving order re-
stricted alternatives. Some of the earliest work closely related to the problems we consider
was conducted by Bartholomew (1959a, 1959b, 1961a, 1961b). With the assumption that
random variables follow univariate normal distributions, Bartholomew successively derived
the likelihood ratio tests (LRTs) for homogeneity of means against monotonic alternatives
(1959a), against two-sided monotonic alternatives (1959b), against more general order re-
strictive alternatives with known variances (1961a), and against order restrictive alternatives
with unknown variances (1961b). The large body of subsequent related work is summarized
in Robertson, Wright, and Dykstra (1988) with more recent developments chronicled by Sil-
vapulle and Sen (2005). Little work has been done to connect order restricted inference to
modern genomics applications. One exception is the work of Peddada et al. (2003) who
proposed a gene clustering algorithm using time-course or dose-response gene expression
profiles.
Although order restricted inference has not played a role, considerable work has been
conducted on the problem of identifying gene sets whose joint expression distributions differ
across treatments. For the most part, these methods can be grouped into two categories.
Methods in one category begin by computing a statistic value for each individual gene;
then the gene-specific values of the test statistic are combined for the genes in a gene set to
determine the significance of the gene set. Methods belonging to this category include the
GSEA by Subramanian et al. (2005), SAFE by Barry et al. (2005), and GSA by Efron and
Tibshirani (2007).
Methods in the other category use a global and multivariate approach to gene set testing.
Tests for differences in multivariate expression distributions across different experimental
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conditions are used to identify gene sets of interest. Such methods include the Global
Test by Goeman (2004), global ANCOVA by Mansmann and Meister (2005), PLAGE by
Tomfohr et al. (2005), DEA by Liu et al. (2007), the Multiresponse Permutation Procedure
(MRPP) described by Mielke and Berry (2001) and used in gene set testing by Nettleton
et al. (2008), the HMM approach incorporating directed acyclic graphs (DAG) by Liang
and Nettleton (2010), the Shrinkage Approach to Gene-set Analysis (SAGA) by Parks et
al. (2011), and the multiple testing considered by Sohn (2011), among others.
In the remainder of this paper,we develop methods of both types that use order restricted
inference to identify gene sets whose gene expression levels tend to change monotonically
with a quantitative or ordinal treatment factor.
3.1.4 Organization
In Section 3.2, we propose four tests for detecting multivariate gene sets comprised of
genes with expression levels that change monotonically as treatment levels increase. We
refer to these tests as the Index Weighted Sum Permutation Test (IWSPT), the Linear Re-
gression Permutation Test (LRPT), the Isotonic Estimator Permutation Test (IEPT) and
the Isotonic Likelihood Ratio Permutation Test (ILRPT). We also provide the asymptotic
null distribution of the isotonic likelihood ratio test statistic for the case of normally dis-
tributed data, based on Bartholomew’s work in late 1950’s and early 1960’s (Bartholomew,
1959a, 1959b, 1961a, 1961b). In Section 3.3, we introduce three tests that do not focus on
monotonic alternatives. We carry out a simulation study to compare our proposed methods
to the other three methods in Section 3.4. In Section 3.5, we apply these procedures to
analyze data reported by Thomas et al. (2007). Results are discussed in Section 3.6.
3.2 Proposed Methods
3.2.1 Method I – Index Weighted Sum Permutation Test (IWSPT)
The first test we propose is based on pairwise Euclidean distances between gene ex-
pression vectors from different treatment groups. If the alternative hypothesis is true, the
observations from within any treatment group should be, relatively speaking, close to each
other and farther from the observations of a different treatment group. Moreover, under
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the alternatives of greatest interest, the larger the difference between the indices |i − i′|,
the farther the distance between the observations from these groups is expected to be. Let
Λ(i, i′) be the average of all the Euclidean distances between pairs of data vectors between
group i and group i′, i.e.,
Λ(i, i′) =
1
nini′
ni∑
j=1
ni′∑
k=1
‖Yij −Yi′k‖. (3.1)
Our proposed test is a weighted sum of all Λ(i, i′) values given by,
SI =
T−1∑
i=1
T∑
i′=i+1
w(i, i′)Λ(i, i′), (3.2)
where w(i, i′) is a non-decreasing function of |i − i′|. Thus, the contribution of Λ(i, i′) to
SI is more heavily weighted when |i − i′| is large. Throughout this paper, we simply use
w(i, i′) = |i− i′|. However, when the ith treatment group is associated with a quantitative
value xi (i = 1, . . . , T ), other choices like w(i, i′) = |xi − xi′ | are simple to implement. For
all such choices of w(i, i′), the null hypothesis is rejected if SI is sufficiently large.
A permutation test is used to obtain a p-value as follows. The treatment labels are
permuted M times relative to the gene set expression vectors, and the test statistic value
for the mth permutation is calculated and denoted SIm (m = 1, . . . ,M). The permutation
p-value is the proportion of the M + 1 test statistic values (the statistic computed for the
original data and the M permutations) no less than the test statistic value observed for the
original data: p =
PM
m=1 I(SIm≥SI)+1
M+1 . Although the total number of permutations is N !,
these N ! permutations give rise to N !QT
i=1 ni!
distinct test statistic values. When N !QT
i=1 ni!
is
too large for the available time and computing resources, a random sample of the N !QT
i=1 ni!
relevant permutation test statistic values may be selected and combined with the observed
statistic to form a valid permutation reference distribution.
It is known that different genes have different variances. The genes with larger variances
may have dominant effects over the genes with smaller variances. In order to adjust the
heterogeneity of variance among genes in a gene set, a Euclidean commensuration approach
was proposed by Mielke and Berry (2001) and utilized by Nettleton et al. (2008) in mul-
tivariate gene set testing. For the problem we consider in this paper, each observation of
gene g, Yijg, is standardized with
T∑
i=1
T∑
i′=i
ni∑
j=1
ni′∑
k=j
(Yijg − Yi′kg)2

− 1
2
, g = 1, . . . , G,
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so that data from each gene have the same sample variance after the standardization.
Throughout this paper, we assume all the genes within a gene set have a same variance, or
have been standardized using Euclidean commensuration.
3.2.2 Methods Based on Combining P-Values from Individual Genes within a
Gene Set
In Sections 3.2.2.1 through 3.2.2.3, we introduce three testing procedures that begin by
computing a test statistic for each individual gene within a gene set. The gene-specific test
statistic differs for each method, but the way the test statistic values are used to draw a
conclusion about the entire gene set is the same for all three methods. We now describe this
approach in general terms before introducing the specific test statistics in Section 3.2.2.1
through 3.2.2.3.
First, the observed test statistics for the G genes in the gene set (denoted by S1, . . . , SG)
are converted to permutation p-values. As described in Section 2.1, the treatment labels are
randomly permuted relative to the gene expression vectors M times. Let Sgm denote the
value of the test statistic computed for gene g and permutation m. This yields G× (M + 1)
values that can be organized in the matrix
S1 S11 · · · S1M
S2 S21 · · · S2M
...
...
. . .
...
SG SG1 · · · SGM

. (3.3)
The first column of this matrix contains the test statistics calculated using the original
data, and the m + 1st column (S1m, . . . , SGm) contains the test statistics calculated using
the mth permutation, m = 1, . . . ,M . Then the permutation p-values for the original data
and the permutation data also construct a G× (M + 1) matrix
p1 p11 · · · p1M
p2 p21 · · · p2M
...
...
. . .
...
pG pG1 . . . pGM

, (3.4)
where the first column are the permutation p-values for gene g using the original data, and
the m+ 1st column contains the corresponding permutation p-values for the mth permuta-
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tion. If the null hypothesis is rejected with large statistic values, then pg =
PM
m=1 I(Sgm≥Sg)+1
M+1
with g = 1, . . . , G, and pgm =
PM
m∗=1 I(Sgm∗≥Sgm)+I(Sg≥Sgm)
M+1 , g = 1, . . . , G, m = 1, . . . ,M . If
the null hypothesis is rejected with small statistic values, then the direction of the sign is
changed from “≥” to “≤” in the above two formulas.
For each column of the p-value matrix, we combine the G elements into one statistic.
There are many different ways to combine p-values: the maximum, the minimum, the mean
or the median of the G p-values, etc. Here we use Fisher’s combined probability method
(1925): X2 = −2∑Gg=1 ln(pg) for the original data and X2m = −2∑Gg=1 ln(pgm) for the
permutation data, m = 1, . . . ,M . For a level α = 0.05 test, the null hypothesis is rejected if
X2 is larger than the 95th percentile among {X2, X21 , . . . , X2M}, i.e., if
PM
m=1 I(X2m≥X2)+1
M+1 <
0.05.
In the following three testing methods described in subsections 3.2.2.1 to 3.2.2.3, we
first compute a test statistic for each gene in a gene set and then combine the result across
genes within a gene set. To simplify notations in these subsections, for gene g (g = 1, ..., G),
we use Yij instead of Yijg to denote the gene expression value for the jth replication under
the ith treatment.
3.2.2.1 Method II – Linear Regression Permutation Test (LRPT)
The second method is motivated by simple linear regression models. Consider a simple
linear regression for each gene in the gene set as follows:
Yij = β0 + β1i+ ij i = 1, . . . , T, j = 1, . . . , ni,
where the ij terms are assumed to be independent, zero-mean random variables with
constant variance. Let |t1| = |βˆ1|sβˆ1 denote the absolute value of the t-statistic for testing β1 =
0 vs. β1 6= 0, where βˆ1 =
PT
i=1 i·ni·Y¯i·−(
PT
i=1 i·ni)Y¯··PT
i=1 i
2·ni− 1N (
PT
i=1 i·ni)2
, and sβˆ1 =
(
1
N−2
PT
i=1
Pni
j=1(Yij−Yˆij)2PT
i=1 i
2·ni− 1N (
PT
i=1 i·ni)2
) 1
2
.
If the alternative hypothesis of interest is true for this gene, |t1| will tend to be large.
Similar testing ideas can be found in Armitage (1955), and Bartholomew (1961a). The
Linear Regression Permutation Test statistic is defined as SII = |t1|. The null hypothesis is
rejected with large SII and the permutation p-value is p =
PM
m=1 I(|t1m|≥|t1|)+1
M+1 , where |t1m|
is the test statistic calculated using the mth permuted data (m = 1, . . . ,M).
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Similar to the IWSPT statistic, using the treatment indices in the LRPT statistic SII
makes it applicable in general cases in which only the treatment indices are available to
use. In the calculation of SII , it is straightforward to use the real values of the treatment
levels as the regressor variable instead of using the treatment indices for the cases where
the treatment factor is numerical.
3.2.2.2 Method III – Isotonic Estimator Permutation Test (IEPT)
The basic idea of IEPT is as follows. If the alternative hypothesis is true, the distance
between the mean gene expression under the first treatment index and the mean gene
expression under the last treatment index should be the larger than the distances between
the mean gene expressions for any other pair of treatments. This idea is motivated by
Peddada et al.’s (2003) method for clustering genes using order-restricted inference.
Suppose µˆ(I) = (µˆ(I)1 , . . . , µˆ
(I)
T )
′ and µˆ(D) = (µˆ(D)1 , . . . , µˆ
(D)
T )
′ are the projections of
(Y¯1·, . . . , Y¯T ·)′ onto the increasing order restricted profile CI = {µ ∈ RT : µ1 ≤ µ2 ≤ · · · ≤
µT } and the decreasing order restricted profile CD = {µ ∈ RT : µ1 ≥ µ2 ≥ · · · ≥ µT },
respectively, using isotonic estimation. Our proposed test statistic for gene g is defined as
SIII = `∞ = max{`(I)∞ , `(D)∞ },
where `(I)∞ ≡ |µˆ(I)1 − µˆ(I)T | and `(D)∞ ≡ |µˆ(D)1 − µˆ(D)T |. The null hypothesis is rejected for large
`∞ values. The permutation p-values is p =
PM
m=1 I(`m∞≥`∞)+1
M+1 , where `
m∞ is the test statistic
calculated from the mth permutation (m = 1, . . . ,M).
3.2.2.3 Method IV – Isotonic Likelihood Ratio Permutation Test (ILRPT)
Consider µˆ(I) = (µˆ(I)1 , µˆ
(I)
2 , . . . , µˆ
(I)
T )
′ ∈ CI and µˆ(D) = (µˆ(D)1 , µˆ(D)2 , . . . , µˆ(D)T )′ ∈ CD de-
fined in Section 3.2.2.2. The corresponding sums of squares are: SSTotal =
∑T
i=1
∑ni
j=1(Yij−
Y¯··)2, SSEI =
∑T
i=1
∑ni
j=1(Yij−µˆ(I)i )2, SSED =
∑T
i=1
∑ni
j=1(Yij−µˆ(D)i )2, SSTI =
∑T
i=1 ni(µˆ
(I)
i −
Y¯··)2, SSTD =
∑T
i=1 ni(µˆ
(D)
i − Y¯··)2. Define the Isotonic Likelihood Ratio Permutation Test
(ILRPT) statistic as SIV = B¯∗ ≡ max{B¯(I), B¯(D)}, where B¯(I) = SSTISSTotal and B¯(D) =
SSTD
SSTotal
.
Permute the treatment labels relative to gene set expression vectors for M times, and the
test statistic using the mth (m = 1, . . . ,M) permuted data B¯∗m is also calculated. The null
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hypothesis is rejected when the statistic value is large enough. The permutation p-values
for ILRPT is p =
PM
m=1 I(B¯∗m≥B¯∗)+1
M+1 .
Consider the assumption that gene expressions follow normal distributions:
Yij ∼ N(µi, σ2), i = 1, . . . , T, j = 1, . . . , ni, (3.5)
with independence among all N ≡∑Ti=1 ni random variables. Also, denote the parameter
space as
θ = (µ1, µ2, . . . , µT , σ2)′ ∈ Θ, Θ = RT × R+.
Under this assumption, µˆI is the MLE of µ under restriction µ1 ≤ µ2 ≤ . . . ≤ µT , and µˆD
is the MLE of µ under restriction µ1 ≥ µ2 ≥ . . . ≥ µT . Also, rejecting the null hypothesis
with B¯∗ large enough is equivalent to rejecting the null hypothesis with the LRT statistic
small enough for testing the hypotheses
H0 : θ ∈ Θ0 vs. H1 : θ ∈ Θ1 = (ΘI ∪ΘD) \Θ0,
where
Θ0 = {θ ∈ Θ : µ1 = µ2 . . . = µT },
ΘI = {θ ∈ Θ : µ1 ≤ µ2 . . . ≤ µT } = CI × R+, and
ΘD = {θ ∈ Θ : µ1 ≥ µ2 . . . ≥ µT } = CD × R+.
The derivation is provided in Section 3.7.1 of the Appendix.
Moreover, with the normal distribution assumption in (3.5), B¯(I) and B¯(D) follow
weighted sums of Beta distributions (Bartholomew, 1961b) under the null hypothesis, i.e.,
P (B¯(I) ≥ c) = P (B¯(D) ≥ c) =
T∑
q=2
w(q,T )P (B(q−1)/2,(N−q)/2 ≥ c), (3.6)
with weights w(q,T ), q = 2, . . . , T . We present the derivation in Section 3.7.2 of the Ap-
pendix.
For the “two-sided” order restricted testing problem discussed in this paper, Bartholomew
(1959b) proposed an approximation method to obtain the critical value:
P (max{B¯(I), B¯(D)} ≥ Cα) ≈ 2P (B¯(I) ≥ Cα) = 2P (B¯(D) ≥ Cα). (3.7)
So the critical value Cα is approximated by the upper α2 quantile of the distribution of
B¯(I) or B¯(D). For balanced data, Table 1 in Bartholomew’s paper (1959a) gives the exact
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values of w(q,T ) q = 2, . . . , T for T ≤ 5. For unbalanced data or T > 5, w(q,T ) can be
approximated using Plackett’s (1954) formula. With modern computers, we are able to
obtain the distribution of B¯(I) (or B¯(D)) and B¯∗ directly using simulation.
3.3 Other Methods that Do Not Focus on Monotonic Alternatives
In this section, we introduce three methods for testing the hypotheses
H0 : F1 = F2 = . . . = FT vs. H1 : not all Fi’s are equal, (3.8)
that do not focus on monotonic trends in gene expression. Again, we use a permutation
procedure to obtain p-values.
3.3.1 Multiresponse Permutation Procedure (MRPP)
The first test we present is the Multiresponse Permutation Procedure (MRPP) intro-
duced by Mielke and Berry (2001). The basic idea of the MRPP is as follows. If the
alternative hypothesis is true, i.e., gene expression vectors under different treatments fol-
low different distributions, then the observation vectors from the same treatment group
will tend to be relatively close together and be farther away from the observation vectors
from a different treatment group. So randomly permuting labels relative to the N gene
set expression vectors is likely to produce greater average pairwise within-group distances
than obtained with the original treatment labels. The MRPP based on this idea is to reject
the null hypothesis for sufficiently small mean pairwise within-group distances. The test
statistic can be written as
D¯ =
∑T
i=1 niDi
N
, (3.9)
where
Di =
1
ni(ni − 1)/2
ni−1∑
j1=1
ni∑
j2=j1+1
‖Yij1 −Yij2‖
is the average pairwise within-group distance.
The treatment labels are permutedM times and the mth permutation test statistic value
is calculated D¯m (m = 1, . . . ,M). The permutation p-value is the proportion of the per-
mutation statistic values no larger than the observed statistic value: p =
PM
m=1 I(D¯m≤D¯)+1
M+1 .
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3.3.2 Energy Statistic (ES)
Another method is based on the concept of an “energy statistic” proposed by Zech
and Aslan (2005). This test was originally applied in multivariate two sample tests. The
statistic is defined as
Φn1n2 =
1
n21
n1−1∑
j=1
n1∑
j′=j+1
R(‖Y1j −Y1j′‖) + 1
n22
n2−1∑
j=1
n2∑
j′=j+1
R(‖Y2j −Y2j′‖)
− 1
n1n2
n1∑
j=1
n2∑
j′=1
R(‖Y1j −Y2j′‖), (3.10)
where n1 and n2 are the sample sizes for the two groups, R(·) is a continuous, monotonically
decreasing function. R(r) = − ln(r) is suggested by the authors. The three terms in the
formula refer to the energies for the two groups and the interaction energy between them.
When the treatment number is greater than 2, the statistic is generalized as follows:
E =
T∑
i=1
1
n2i
ni−1∑
j=1
ni∑
j′=j+1
R(‖Yij −Yij′‖)
−
∑
i>i′
1
nini′
ni∑
j=1
ni′∑
j′=1
R(‖Yij −Yi′j′‖), T ≥ 2. (3.11)
P-values are obtained using a permutation procedure. Gene sets with large statistic values
will be identified as having significant differences between treatment groups. So for a pro-
cedure with M permutations, the permutation p-value is p =
PM
m=1 I(Em≥E)+1
M+1 , where Em
is the test statistic calculated from the mth (m = 1, . . . ,M) permutation.
3.3.3 Permutation Based ANOVA Test (PANOVA)
One-way ANOVA provides a good default test in testing overall homogeneity of means
for one-dimensional data satisfying the assumption of normality. When the data fails to
satisfy the assumption of normality and the sample size is too small, the F null distribution
for the test statistic may not be reliable. In this case, we conduct a permutation test for
each gene using the ANOVA F-statistic as the test statistic. For multi-dimensional data
analyses, such as the gene set detections in this paper, we follow the procedure discussed
in Section 2.2, so as to use Fisher’s (1925) probability combination method to obtain the
permutation p-value for the whole gene set.
55
3.4 Simulation Studies
In this section we use three simulation studies to compare the four tests that consider
monotonic alternatives and the three methods that do not focus on monotonic alternatives.
3.4.1 The First Simulation Study
In the first study, we generate data from multivariate normal distributions with dimen-
sions = 6 and 20 under: 1. the null case for which the simulated gene expression distribution
remains the same across different treatments; 2. the alternative for which the mean values
increase linearly, exponentially or logarithmically as a function of treatment level in each
dimension, which is the first monotonic case; 3. another alternative case for which the mean
values increase in an arc-tangental manner in all dimensions, which is the second monotonic
case; and 4. the case for which the mean values change with different treatment levels but
do not change monotonically as the treatment levels increase. We use the first-order autore-
gressive structure as the correlation structure for all the simulated gene expressions within a
independent simulation replication. The number of treatment levels is T = 5, the number of
replicates under each treatment level is ni = 3 (i = 1, . . . , 5). A total of 1, 000 independent
simulation replications are simulated under each simulation setting. We do tests using our
proposed four test statistics, compared with the MRPP, the Energy Statistic (ES), and the
PANOVA. We did 1, 000 permutations including the original data to obtain one p-value. A
gene set is identified if its permutation p-value is smaller than 0.05. Because we focus on
single gene set detections, we do not discuss challenges in multiple testing that arise when
many gene sets are tested simultaneously. Recent studies in this area include Liang and
Nettleton (2010) and Sohn et al. (2011). Estimated detection rates from this simulation
study using 6 genes in a gene set are shown in Table 3.1. Estimated detection rates from
this simulation study using 20 genes in a gene set are shown in Table 3.2.
1000 gene sets in each case ES PANOVA MRPP IWSPT LRPT IEPT ILRPT
Null 38 42 39 45 53 45 46
Monotonic case 1 725 732 720 931 962 923 946
Monotonic case 2 723 735 724 924 946 921 940
Not Monotonic 723 709 721 11 3 26 40
Table 3.1: Monotonic gene set detections using different statistics with normal random
variables. Each gene set contains 6 genes.
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1000 gene sets in each case ES PANOVA MRPP IWSPT LRPT IEPT ILRPT
Null 53 54 49 50 57 59 52
Monotonic case 1 990 989 990 1000 1000 1000 1000
Monotonic case 2 980 984 985 1000 1000 1000 999
Not Monotonic 978 982 978 5 0 22 23
Table 3.2: Monotonic gene set detections using different statistics with normal random
variables. Each gene set contains 20 genes.
From Table 3.1, we can see that under both monotonic cases, the proposed test statistics
have more identifications than the other three methods when the gene expressions change
monotonically as the treatment level increases. In both cases where gene expressions change
monotonically, all the four proposed tests have identification rates over 90%, while the three
existing tests have identification rates around 79%. Among all the tests, LRPT and ILRPT
have the best power. When gene expression changes across the treatment labels but not
in a monotonic pattern, ES, PANOVA and MRPP have identification rates similar to the
two monotonic cases, while none of the four proposed test statistics reject more than 4% of
the gene sets. We can see that our proposed tests focus detection power on monotonically
changing expression patterns, which is a sub-space of the complement of the null parameter
space, while the other three methods spread detection power over the complement of the
null parameter space. Thus the proposed tests have more detections for gene sets that
contain genes whose expression levels tend to change monotonically across treatments than
other methods.
From Table 3.2, we can see that when the number of genes in a gene set increases to 20,
all the testing methods have an increased number of identifications in both monotonic cases.
The proposed IWSPT, IRPT and IEPT identify all of the gene sets with monotonic changing
patterns. The ILRPT identifies all the gene sets with monotonic changing pattern 1, and
999 gene sets of the total 1, 000 gene sets with monotonic changing pattern 2. Although
other tests also identify most of the gene sets in the two monotonic cases, their numbers of
identifications are still significantly less than the proposed tests. In the case that the gene
expression means are different across treatment levels but not monotonically related to the
treatment index, most of the gene sets are not rejected by the proposed tests. Actually, the
numbers of gene sets rejected by the proposed tests are even slightly less than the number
of gene sets rejected in the non-monotonic case when the dimension is 6. On the contrary,
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the numbers of rejections by the tests that do not focus on monotonic change patterns are
similar to the number of rejections in both monotonic cases.
3.4.2 The Second Simulation Study
In the second simulation study, we compare ILRPT with the test using test statistic B¯∗
and the critical value from Bartholomew’s approximation, and the test using B¯∗ and the
critical value approximated by simulation. We focus exclusively on univariate analysis for
a single gene and consider the case where T = 5 and ni = 3 for i = 1, . . . , 5.
For the Bartholomew’s critical value approximation, we use the upper 2.5% percentile
of the null distribution of B¯(I) (or B¯(D)) as an approximation of the upper 5% percentile
of the null distribution of B¯∗ = max{B¯(I), B¯(D)}. By Bartholomew (1959a, 1961b),
PH0(B¯
(I) ≥ c) = PH0(B¯(D) ≥ c) =
5∑
q=2
w(q,5)P (B(q−1)/2,(15−q)/2 ≥ c),
where w(2,5) = 50120 , w(3,5) =
35
120 , w(4,5) =
10
120 , w(5,5) =
1
120 . Thus we obtain the critical
value C1 = 0.41962.
For the critical value directly obtained by simulation, we simulate the empirical distri-
bution of B¯∗ under the null hypothesis using normal data. The upper 5% percentile of
the empirical distribution is an approximation of the exact critical value. We simulated
3, 000, 000 null data set to obtain the critical value C2 = 0.4198589. We can see that with
α = 0.05, the two critical value approximations are actually very close.
We compare ILRPT with tests using C1 and C2 based on a simulation involving 10, 000
normally distributed data sets for each of four cases. The results are presented in Table 3.3.
From Table 3.3, we can see that all four proposed test statistics show larger powers and
better specificities relative to the methods that do not focus power on ordered alternatives.
The ILRPT results are similar to the results for which the two critical values are obtained
by approximations.
3.4.3 The Third Simulation Study
In the third simulation study, we replicate the second simulation study except that nor-
mal distributions are replaced with gamma distributions. The results using the gamma
distribution with α-level 0.05 are shown in Table 3.4. We found that the tests that do not
58
10000 genes in each case ES PANOVA MRPP IWSPT LRPT IEPT ILRPT C1 C2
Null 452 454 466 470 521 490 498 490 487
Monotonic case 1 6508 6805 6525 8984 9388 8816 9069 9077 9076
Monotonic case 2 6485 6831 6521 8761 8975 8625 8916 8916 8933
Not Monotonic 6454 6819 6471 119 54 358 406 418 417
Table 3.3: Monotonic Gene Detections Using Different Statistics with Normal Random
Variables
focus power on monotonic patterns have low identification rates in the second monotonic
case, while the proposed tests have good identification rates for both cases in which gene
expression changes monotonically as the treatment level increases. Moreover, the proposed
tests have fewer rejections in the case for which changes in gene expression are not mono-
tonic. Also, the results using critical values C1 and C2 are very similar to the result of
ILRPT.
10000 genes in each case ES PANOVA MRPP IWSPT LRPT IEPT ILRPT C1 C2
Null 530 509 511 440 516 520 507 503 500
Monotonic case 1 5075 4588 5076 7215 7472 6850 7023 7064 7059
Monotonic case 2 3581 3781 3564 5926 6472 5922 6202 6228 6221
Not Monotonic 8379 7553 8478 21 27 20 22 14 14
Table 3.4: Monotonic Gene Detections Using Different Statistics using Gamma Random
Variables
3.5 An Example with Real Data Analysis
In this section, we apply all the methods introduced in this paper to analyze mouse
gene expression data from Thomas et al. (2007). The aim is to detect gene sets that have
expressions that monotonically change with exposure to increasing formaldehyde, with level
of concentration 0 (control group, exposed to filtered air), 0.7, 2.0, 6.0 and 15.0 ppm. The
experiment used 8 mice for the control group and 4 mice for each non-zero formaldehyde
concentration. After exposure for 6 hours, the mice were sacrificed, and the gene expression
values were obtained (with log-2 transformation) and stored in Biotechnology Information
Gene Expression Omnibus. The information of Gene Ontology annotation is obtained by
using rat2302.db and annotate R Bioconductor packages. We use the four proposed
testing procedures to identify multivariate monotonic gene expressions, and compare the
results with the three tests that do not focus on monotonic changes. We identify gene sets
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with permutation p-values smaller than 0.05 as significant.
The gene sets identified by all of the MRPP, ES and PANOVA tests but none of the
proposed tests are shown in Figure 3.1 and Figure 3.2. Each panel is for genes from a
single gene set. The labels 1 through 5 on the horizontal axis in each panel denote the
five formaldehyde concentrations, i.e., the five treatment levels. The standardized log-2
mean gene expression levels for each individual gene are connected by line segments. We
can see that the gene sets shown in Figure 3.1 and 3.2 have different mean gene expression
levels across the treatments, but the changing patterns are not monotonic. One example
is Gene Set 1 shown in the upper left panel of Figure 3.1, which has an “up – down – up”
pattern. When the formaldehyde concentration changes from 0 ppm to 0.7 ppm, the mean
genes expression levels of genes in Gene Set 1 tend to increase. This increase is followed
by a decreasing change when the concentration increases from 0.7 ppm to 6.0 ppm. Gene
expression tends to increase again when the formaldehyde concentration increases to 15.0
ppm. Some other gene sets have a “down – up – down” pattern, such as Gene Sets 4, 10
and 13. There are also some gene sets with more than one gene expression trend. Some
examples are Gene Set 5 and 9, which have an “up – down – up” pattern and a “down – up
– down” pattern in the same gene set. None of these gene sets have significant monotonic
gene expression patterns.
Figure 3.3 through Figure 3.5 show five examples of the gene sets detected by all four
of the proposed tests. The gene sets are the same from Figure 3.3 to Figure 3.5. The
genes in red color in Figure 3.3 have permutation p-values less than 0.05 when doing single
gene analysis using LRPT, and the genes in red color in Figure 3.4 and Figure 3.5 have
permutation p-values less than 0.05 when doing single gene analysis using IEPT and ILRPT,
respectively. In Gene Set D, it is clear that all the genes in red color have a predominantly
decreasing pattern. Other gene sets, for example Gene Set C and Gene Set E, have some
genes with a decreasing pattern and other genes with an increasing pattern. We can see
that differences among Figures 3.3 through 3.5 are very slight.
3.6 Discussion and Conclusions
In this paper, we consider the case where an experimental treatment factor is numerical
or ordinal and the response variable is a measure of gene expression. We propose four tests:
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Figure 3.1: Gene Sets Identified by All the Old Tests But None of the New Tests
the Index Weighted Sum Permutation Test (IWSPT), the Linear Regression Permutation
Test (LRPT), the Isotonic Estimator Permutation Test (IEPT) and the Isotonic Likelihood
Ratio Permutation Test (ILRPT), to detect multivariate gene sets that contain genes with
monotonic changes in means when increasing the treatment level. Other multivariate tests,
such as the Multiresponse Permutation Procedure (MRPP), the Energy Statistic (ES) and
the Permutation Based ANOVA Test (PANOVA), spread power over the entire complement
of the null parameter space, and do not focus more power on the monotonic subspace.
By simulation, we demonstrate that the proposed tests have higher detection powers
when the gene expression levels in multivariate gene sets change monotonically in mean
values, compared to tests that do not focus on monotonic changes. In the application of all
the testing methods to a real data set, we found that the gene sets detected by all of the
proposed tests contain genes with monotonic changes in their mean gene expression levels,
while the gene sets detected by the other three tests have gene expression patterns that are
not monotonic.
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Figure 3.2: Gene Sets Identified by All the Old Tests But None of the New Tests
3.7 Appendix
3.7.1 Derivation of the Isotonic Likelihood Ratio Test Statistic
Let Yi = (Yi1, . . . , Yini)
′, i = 1, . . . , T . The ratio of the supremum of likelihoods under
the null hypothesis parameter space and the whole parameter space is
Λ =
supθ∈Θ0
∏T
i=1 f(Yi;θ)
supθ∈Θ0∪Θ1
∏T
i=1 f(Yi;θ)
=
e
−N
2
( 2piN SSTotal)
N
2
max
{
e−
N
2
( 2piN SSEI)
N
2
, e
−N2
( 2piN SSED)
N
2
}
=
min
{(
2pi
N SSEI
)N
2 ,
(
2pi
N SSED
)N
2
}
(
2pi
N SSTotal
)N
2
.
Thus, the LRT statistic is
− 2 log Λ = −2
{
N
2
log min {SSEI , SSED} − N2 logSSTotal
}
= −N min
{
log
SSEI
SSTotal
, log
SSED
SSTotal
}
.
3.7.2 The null distribution of B¯(I)
In this section, we review the derivation of the null distribution of B¯(I), derived by
Bartholomew (1959a, 1961b). The null distribution of B¯(D) is the same as B¯(I).
62
1 2 3 4 5
-1
.0
0
.0
1
.0
2
.0
Gene Set A
1 2 3 4 5
-1
.5
-0
.5
0
.5
1
.5
Gene Set B
1 2 3 4 5
-1
.5
-0
.5
0
.5
1
.5
Gene Set C
1 2 3 4 5
-1
.0
0
.0
1
.0
Gene Set D
1 2 3 4 5
-1
.5
-0
.5
0
.5
1
.5
Gene Set E
Figure 3.3: Examples for the Gene Sets Identified by All the Proposed Tests (Genes with
permutation p-values smaller than 0.05 in LRPT single gene data analysis are shown in red
color.)
First, we obtain the formulas of SSTI and SSEI . For group means {Y¯1., . . . , Y¯T.}, there
is a unique subset S = {0 = i0 < i1 < . . . < iq = T} ⊂ {0, 1, . . . , T}, such that
Y¯[1,i1] = Y¯[i0+1,i1] < Y¯[i1+1,i2] < Y¯[i2+1,i3] < . . . < Y¯[iq−1+1,iq ] = Y¯[iq−1+1,T ],
where Y¯[ir−1+1,ir] = (
∑ir
i=ir−1+1 niY¯i)/(
∑ir
i=ir−1+1 ni) is the mean of the gene expressions
from group ir−1 + 1 to group ir. The number of samples from group ir−1 + 1 to group ir
is denoted as n[ir−1+1,ir] =
∑ir
i=ir−1+1 ni. Also, Y¯[ir−1+1,ir] is no less than any of the groups
means with index smaller than ir−1 + 1, and is no larger than any of the group means with
index larger than ir, i.e.,
max{Y¯1·, . . . , Y¯ir−1·} ≤ Y¯[ir−1+1,ir] ≤ min{Y¯ir+1·, . . . , Y¯T ·}.
So µˆ(I)i = Y¯[ir−1+1,ir], ir−1 + 1 ≤ i ≤ ir, r = 0, . . . , q, and
SSTI =
q∑
r=1
n[ir−1+1,ir](Y¯[ir−1+1,ir] − Y¯··)2,
SSEI =
q∑
r=1
ir∑
i=ir−1+1
ni∑
j=1
(Yij − Y¯[ir−1+1,ir])2.
For example, if Y¯1· < . . . < Y¯T., then q = T , ir = i (r = 1, . . . , T ). So µˆ
(I)
i = Y¯i·,
SSTI = SST and SSEI = SSE. For another example, if Y¯1· ≥ . . . ≥ Y¯T ·, then q = 1, so
µˆ
(I)
1 = . . . = µˆ
(I)
T = Y¯··, SSTI = 0.
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Figure 3.4: Examples for the Gene Sets Identified by All the Proposed Tests (Genes with
permutation p-values smaller than 0.05 in IEPT single gene data analysis are shown in red
color.)
Once the formulas for SSTI and SSEI are obtained, we begin to derive the asymptotic
null distributions for SSTI and SSEI . According to the statement above, given group
means Y¯1·, . . . , Y¯T ·, there is a unique subset S = {i0, i1, . . . , iq−1, iq}. Based on that, the
distribution of SSEI is
P (SSEI ≥ c | Y¯[1,i1] ≤ ... ≤ Y¯[iq−1+1,T ])
= P
( q∑
r=1
ir∑
i=ir−1+1
ni∑
j=1
(Yij − Y¯[ir−1+1,ir])2 ≥ c
∣∣∣∣ Y¯[1,i1] ≤ ... ≤ Y¯[rq−1,T ]),
Since the within group sum of square
∑q
r=1
∑ir
i=ir−1+1
∑ni
j=1(Yij − Y¯[ir−1+1,ir])2 is irrelevant
with the order of group means Y¯[1,i1] ≤ ... ≤ Y¯[rq−1,T ], the conditional probability is equal
to the unconditional probability, i.e.,
P
( q∑
r=1
ir∑
i=ir−1+1
ni∑
j=1
(Yij − Y¯[ir−1+1,ir])2 ≥ c
∣∣∣∣ Y¯[1,i1] ≤ ... ≤ Y¯[rq−1,T ])
= P
( q∑
r=1
ir∑
i=ir−1+1
ni∑
j=1
(Yij − Y¯[ir−1+1,ir])2 ≥ c
)
= P (χ2N−q ≥ c).
So SSEI is a χ2 random variable with degree of freedom N − q.
For the distribution of P (SSTI ≥ c | Y¯[1,i1] ≤ ... ≤ Y¯[rq−1,T ]), consider the following
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Figure 3.5: Examples for the Gene Sets Identified by All the Proposed Tests (Genes with
permutation p-values smaller than 0.05 in ILRPT single gene data analysis are shown in
red color.)
equation:
T∑
i=1
Wi(Zi − Z¯·)2 =
∑∑
i<j
WiWj(Zi − Zj)2/
T∑
i=1
Wi,
where Z¯· =
PT
i=1 WiZiPT
i=1 Wi
. So we have
P (SSTI ≥ c | Y¯[1,i1] ≤ ... ≤ Y¯[iq−1+1,T ])
= P
( q∑
r=1
n[ir−1+1,ir](Y¯[ir−1+1,ir] − Y¯..)2 ≥ c
∣∣∣∣ Y¯[1,i1] ≤ ... ≤ Y¯[rq−1,T ])
= P
(∑∑
1≤s<r≤q
n[ir−1+1,ir]n[is−1+1,is](Y¯[ir−1+1,ir] − Y¯[is−1+1,is])2 /
q∑
r=1
n[ir−1+1,ir] ≥ c
∣∣∣∣
Y¯[1,i1] ≤ . . . ≤ Y¯[rq−1,T ]
)
.
Because (Y¯[ir−1+1,ir] − Y¯[is−1+1,is])2 is the square of a normal random variable with mean 0,
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which has distribution irrelevant with the order of Y¯[1,i1] through Y¯[rq−1,T ], we have
P
(∑∑
1≤s<r≤q
n[ir−1+1,ir]n[is−1+1,is](Y¯[ir−1+1,ir] − Y¯[is−1+1,is])2 /
q∑
r=1
n[ir−1+1,ir] ≥ c
∣∣∣∣
Y¯[1,i1] ≤ ... ≤ Y¯[rq−1,T ]
)
= P
(∑∑
1≤s<r≤q
n[ir−1+1,ir]n[is−1+1,is](Y¯[ir−1+1,ir] − Y¯[is−1+1,is])2 /
q∑
r=1
n[ir−1+1,ir] ≥ c
)
= P (
q∑
r=1
n[ir−1+1,ir](Y¯[ir−1+1,ir] − Y¯..)2 ≥ c)
= P (χ2q−1 ≥ c).
Consequently, for a given q, the conditional distribution of SSTI is χ2q−1. By Bartholomew
(1959a), the conditional distribution of B¯(I) is Beta with parameters (q−1)/2 and (N−q)/2,
i.e., B(q−1)/2,(N−q)/2. Due to the different orders among Y¯1., . . . , Y¯T., q goes from 1 to T ,
with probability P (#S = q + 1) = w(q,T ), q = 1, . . . , T . So we have P (B¯(I) ≥ c) =∑T
q=2w(q,T )P (B(q−1)/2,(N−q)/2 ≥ c). By the same reasoning, P (B¯(D) ≥ c) =
∑T
q=2w(q,T )P (B(q−1)/2,(N−q)/2 ≥
c).
66
References
Armitage, P. (1955). Tests for linear trends in proportions and frequencies. Biometrics, 11,
375–386.
Ashburner, M, Ball, C. A. , Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis,
A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver,
L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G.
M., Sherlock, G. (2000). Gene ontology: tool for the unification of biology. The Gene
Ontology Consortium(2000). Nature Genetics, 25, 25–29.
Barry, W. T., Nobel, A. B., and Wright, F. A. (2005). Significance Analysis of Functional
Categories in Gene Expression Studies: a Structured Permutation Approach. Bioinfor-
matics, 21, 1943–1949.
Bartholomew, D. J. (1959a). A Test of Homogeneity for Ordered Alternatives. Biometrika,
46, 36–48.
Bartholomew, D. J. (1959b). A Test of Homogeneity for Ordered Alternatives. II.
Biometrika, 46, 328–335.
Bartholomew, D. J. (1961a). A Test of Homogeneity of Means Under Restricted Alterna-
tives. Joural of Royal Statistical Society, Series B, 23, 239–281.
Bartholomew, D. J. (1961b). Ordered Tests in the Analysis of Variance. Biometrika, 48,
325–332.
Efron, B. and Tibshirani, R. (2007). On Testing the Significance of Sets of Genes. Annals
of Applied Statistics, 1, 107–129.
Fisher, R. A. (1925). Statistical Methods for Research Workers. Edinburgh: Oliver and
Boyd.
67
Goeman, J. J., van de Geer, S. A., de Kort, F., and van Houwelingen, H. C. (2004). A Global
Test for Groups of Genes: Testing Association with a Clinical Outcome. Bioinformatics,
20, 93–99.
Hwang, J. and Peddada, S. (1994). Confidence interval estimation subject to order restric-
tions. Annals of Statistics, 22, 67–93.
Liang, K. and Nettleton, D. (2010). A hidden Markov model approach to testing multi-
ple hypotheses on a tree-transformed Gene Ontology graph. Journal of the American
Statistical Association, 105, 1444–1454.
Liu, J., Hughes-Oliver, J. M., and Menius, J. A. (2007). Domain-enhanced analysis of
microarray data using GO annotations. Bioinformatics, 23, 1225–1234.
Mansmann, U. and Meister, R. (2005), Testing Differential Gene Expression in Functional
Groups. Goeman’s Global Test versus an ANCOVA Approach. Methods of Information
in Medicine, 44, 449–453.
Mielke, P. W. and Berry, K. J. (2001) Permutation Methods: A Distance Function Approach.
New York: Springer.
Nettleton, D., Recknor, J., and Reecy, J. M. (2008), Nettleton, D., Recknor, J., and Reecy,
J. M. (2008), Identification of Differentially Expressed Gene Categories in Microarray
Studies using Nonparametric Multivariate Analysis. Bioinformatics, 24, 192–201.
Parks, D. C., Lin, X., Parks, J. J., Menius, J. A., and Lee, K. R. (2011) A Shrinkage
Approach to Gene-Set Analysis. Statistics in Biopharmaceutical Research, 3, 506–514.
Peddada, S. D., Lobenhofer, L., Li, L., Afshari, C., Weinberg, C., and Umbach, D. (2003).
Gene selection and clustering for time-course and dose-response microarray experiments
using order-restricted inference. Bioinformatics, 19, 834–841.
Plackett, R. L. (1954). A reduction formula for normal multivariate integrals. Biometrika,
41, 351-360.
Robertson, T., Wright, F. T., and Dykstra, R. L. (1988). Order restricted statistical infer-
ence. New York: Wiley.
68
Silvapulle, M. J. and Sen, P. K. (2005). Constrained Statistical Inference: Inequality, Order,
and Shape Restrictions. Hoboken, NJ: Wiley.
Sohn, I., Owzar, K., Lim, J., George, S. L., Cushman, S. M., and Jung, S. (2011). Multiple
testing for gene sets from microarray experiments. BMC Bioinformatics, 12, 209.
Subramanian, A., Tamayo, P., Mootha, V., Mukherjee, S., Ebert, B., Gillette, M.,
Paulovich, A., Pomeroy, S., Golub, T., Lander, E., and Mesirov, J. P. (2005), Gene
Set Enrichment Analysis: A Knowledge-based Approach for Interpreting Genome-wide
Expression Profiles. Proceedings of the National Academy of Sciences, 102, 15545–15550.
Thomas, R., Allen, B., Nong, A., Yang, L., Bermudez, F., Clewell, H. and Andersen, M.
(2007). A Method to Integrate Benchmark Dose Estimates with Genomic Data to Assess
the Functional Effects of Chemical Exposure. Toxicological Sciences, 98 , 240–248.
Tomfohr, J., Lu, J., and Kepler, T. B. (2005). Pathway level analysis of gene expression
using singular value decomposition. BMC Bioinformatics, 6, 225.
Zech, G. and Aslan, B. (2005). A Multivariate Two-Sample Test Based on the Concept of
Minimum Energy. Proceedings of Phystat2003, SLAC, Stanford.
69
CHAPTER 4. Copy Number Variation Detection Using Next Generation
Sequencing Read Counts
Abstract
A copy number variation (CNV) is a difference between genotypes in the number of
copies of a genomic region. Next generation sequencing (NGS) technologies provide sensi-
tive and accurate tools for detecting genomic variations that inlcude CNVs. We propose a
new methodology for detecting CNVs using NGS data. This method (henceforth denoted
by m-HMM) is based on a hidden Markov model with emission probabilities that are gov-
erned by mixture distributions. We use the Expectation-Maximization (EM) algorithm to
estimate the parameters in the model. A simulation study demonstrates that our proposed
m-HMM approach improves upon existing methods. We apply the m-HMM method to NGS
data from the two maize inbred lines B73 and Mo17 to identify CNVs that may play a role
in creating phenotypic differences between these inbred lines. We show that the results of
our m-HMM analysis are concordant with previous array-based efforts to identify CNVs.
KEY WORDS: Count data; Gamma-Poisson mixture; Hidden Markov model; Plant ge-
nomics; Poisson mixture model.
4.1 Introduction
A copy number variation (CNV) is a variation between genomes in the number of copies
of a genomic region that is 1,000 DNA bases (1Kb) or larger (Banerjee et al., 2011). CNVs
are also known as structural variations (SVs) because they affect relatively large regions in
a DNA molecule. Structural genomic duplications or deletions correspond to copy number
gains or losses, respectively. CNVs plays an important role in human hereditary illnesses
(Gokcumen et al., 2009) and in plant breeding and agricultural improvement (Schnable et
al., 2009).
70
Maize exhibits extensive variation in both genotype and phenotype relative to the varia-
tion seen in humans (Buckler et al., 2006). The genotypic diversity in maize species permits
a variety of uses, such as human and animal food and fuel. The maize genotype B73 was
sequenced in 2009 (Schnable et al., 2009). This accomplishment allows a further compar-
ison and understanding in different types of maize. Swanson-Wagner et al. (2009) and
Belo et al. (2010) compared a variety of maize inbreds with B73 using array comparative
genomic hybridization (aCGH) and identified a considerable number of CNVs along the
genome. Springer et al. (2009) also analyzed the structural variance between the two maize
genotypes B73 and Mo17 using aCGH.
Array comparative genomic hybridization, first proposed in 1997 (Solinas-Toldo et al.,
1997), has served as a robust and effective approach for CNV screening (Feuk, 2006).
Statistical methods for analyzing aCGH data are readily available and are described in
review articles such as Wineinger et al. (2008) and Medvedev et al. (2009). However,
aCGH is expensive and has limited resolution and accuracy. Nowadays, rapidly developing
next generation sequencing (NGS) technologies provide a sensitive and accurate alternative
approach for accessing genomic variations. The quality, speed, and affordability give NGS
a significant advantage over microarrays (Hurd et al., 2009; Su et al., 2011).
Despite the advantages of NGS over aCGH, the use of NGS for CNV identification has
been limited by a lack of available and effective statistical approaches. The well-developed
aCGH data analysis methods cannot take the full advantage of NGS data, and thus, new
statistical analysis methods for NGS data are needed. Most of the existing methods for CNV
detection using NGS data can be classified into two categories: sliding window methods
and Hidden Markov model (HMM) methods. Sliding window methods include Segseq by
Chiang et al. (2009), Event-wise testing by Yoon et al. (2009), rSW-seq by Kim et al.
(2010) and JointSLM by Magi et al. (2011), among others. This category of methods must
simultaneously deal with a large number of tests of significance, and the results of such
methods are highly dependent on the determination of critical values. One example of
the methods using HMMs is CNAseg by Ivakhno et al. (2010), which requires multiple
sequencing samples for each of the genotypes in the comparison.
In this paper, we propose a new CNV change point detection methodology for use with
NGS data originating from two different genomes. To understand the data and our model
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for the data, it is necessary to introduce some NGS data collection details and terminology.
First of all, we use reference genome to describe the genome of the genotype that has been
fully sequenced using whole-genome sequencing technologies. In contrast, the target genome
is the genome of a genotype of interest that has not been fully sequenced. The goal is to
use NGS data from the reference and target genotypes to identify regions of copy number
variation between the reference and target genomes. We say that a genomic region in the
target genotype where the number of copies is amplified relative to the reference genotype
has a copy number gain. A target genomic region present but at a reduced copy number
relative to the reference genome, is said to have a copy number loss. A region that is present
in the reference genome but absent in the target genome is described as absent. These three
states (copy number gain, copy number loss, and absent) represent copy number variations
in the target genome relative to the reference. A region with no difference in the number
of copies between the target and the reference genotypes is said to be normal in state. A
genomic location where there is a change from one copy number state to another is called
a copy number change point.
To identify copy number change points and copy number states, thousands of genomes
from both the target and the reference genotypes are obtained. The DNA strands are
fragmented into 100 to 1, 000 base segments, and a sample of these segments is obtained
separately for each genotype. At one end of every sampled segment, a sequence of 30 to 70
bases is determined and recorded. Such a sequence of bases is called a read. Each of the
reads is then aligned to the reference genome to determine its origin in the genome. The
location of the first base of the read on the reference genome is recorded as the position
of the read. The numbers of reads for the target genome and the reference genome are
recorded as the target read counts and the reference read counts. If a location has a positive
target read count or a positive reference read count, it is called a site. Thus, data from
NGS technologies are small integer counts with associated site positions on the reference
genome.
In this paper, we proposed a statistical methodology, involving a Hidden Markov model
with mixture emission distributions (m-HMM), to identify and classify regions of CNV
between a target and a reference genome. The proposed m-HMM makes a segmentation
according to the reference genomic locations and identifies regions in the target genome
72
where the copy numbers are different from the reference genome. A formal description of
the data set to be analyzed in presented in Section 4.2. In Section 4.3, we introduce our
proposed m-HMM in full detail. The computational algorithms and analysis details are
explained in Sections 4.4 and 4.5. In Section 4.6, our proposed m-HMM is compared with
other methods using a simulation study. The application of the m-HMM is demonstrated
in Section 4.7 with an analysis of two maize inbred lines: B73 and Mo17, where B73 is the
reference genome and Mo17 is the target genome. Conclusions are provided in Section 4.8.
4.2 The Data Set in this Study
The data to be analyzed can be described as follows. Suppose o[r]i and o
[t]
i are the
observed read counts for the reference genome B73 and the target genome Mo17 at genomic
position bi , i = 1, . . . , I. The read counts take small non-negative integer values, including
a large number of zeros. Because it is difficult to carry out accurate modeling and inference
using such data, it is common to work with sums of counts rather than the original individual
counts.
A common way to group individual counts is to define windows with a specific width and
calculate the sum of target and reference read counts within each window, so as to obtain
shorter series of larger target and reference read counts. Kim et al. (2010) defined windows
using a fixed number of read counts in the reference genome. Chiang et al. (2009), Xie at
al. (2009) and Ivakhno et al. (2010) defined windows using a fixed genomic distance. These
methods have an underlying assumption that the sites within a window share the same
copy number state. Such an assumption may be reasonable because a CNV is a somewhat
rare type of genomic mutation, and the closer any two sites are located on the genome, the
less likely there is a CNV change point between these sites. For example, if a site is in a
genomic region that has been duplicated in the target genome relative to the reference, it
is likely that a nearby site falls within that same region of duplication. However there are
also some problems in implementing these methods. Sites are randomly located along a
genomic sequence, with a high density in some parts of the genome and a low density in
other parts of the genome. Rigidly defining windows with a fixed number of read counts
has the potential to put sites physically far away with each other into one window, which
increases the risk of including copy number change points in a window. Rigidly defining
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the windows with a fixed genomic distance can produce high variation in the number of
sites and in read counts across windows. This can lead to decreased accuracy for identifying
CNVs.
In this paper, we propose a new grouping method, which uses K-means clustering on
the physical site positions to group the sites into windows. For each chromosome, we first
divide the chromosome into M + 1 parts, by defining breakpoints that correspond to the
M largest distances between adjacent sites. In practice, we use M = 20. Then we perform
the K-means clustering for each of the M + 1 parts, where K is chosen for any particular
part as the number of reference genomic sites in the part divided by 40. Thus, each cluster
will have 40 reference genome sites on average. Finally, we obtain W windows, where each
window is defined by a collection of sites in one cluster. For w = 1, . . . ,W , let gw denote the
set of indices corresponding to sites in window w. The target and reference read count for
window w are the sum of the target read counts and the sum of the reference read counts
within that window: u[t]w =
∑
i∈gw o
[t]
i , u
[r]
w =
∑
i∈gw o
[r]
i . We use the median position of
sites within a window as the position for that window. Using this method, the sites that
are closest together have a larger chance to be grouped into a single window, which results
in a more reasonable grouping than previously used approaches.
4.3 Mixture-Hidden Markov Model (m-HMM)
In this section, we describe the proposed mixture-hidden Markov model (m-HMM) that
we use to estimate the copy number change points along the genome. This CNV detecting
methodology is carried out separately on each chromosome. In the hidden Markov model,
we assume that the unobserved copy number states for the windows along the genome
follow a Markov chain, with some unknown transition probability matrix that specifies the
conditional probabilities of transitioning to each state given the current state. Given each
copy number state, the target and the reference read counts are generated according to a
distribution known as the emission distribution.
4.3.1 Transition Probability
For each window w (w ∈ {1, . . . ,W}), we wish to predict one of the four hidden states
Sw ∈ {1, 2, 3, 4}, where
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1 = gain: copy number gain / amplification in the target relative to the reference,
2 = normal: no difference in copy number between the target and the reference,
3 = loss: region present in the target genome but at reduced copy number relative to the
reference,
4 = absent: region absent in the sample but present in the reference.
For the copy number states k and l, the transition probability akl (k, l = 1, . . . , 4) is
defined as, the conditional probability of the next window w + 1 taking copy number state
l, given the copy number state k for the current window w. Motivated by Marioni et al.
(2006), we define the transition matrix for each window w as a function of w given by
Aw = [akl(w)]4×4, where
akl(w) = P (Sw+1 = l|Sw = k,θ)
=

pkl(1− e−ρdw) l 6= k
1− (∑j 6=k pkj)(1− e−ρdw) l = k , (4.1)
for k, l = 1, . . . , 4 and w = 1, . . . ,W − 1. Here dw denotes the physical distance on the
reference genome between the location of window w and the location of window w+ 1. The
parameter pkl affects the transition probabilities from state k to state l, regardless of the
distances between adjacent windows. We constrain pkl ∈ (0, 1) and
∑
l 6=k pkl < 1 for each
k. The parameter ρ is a positive-valued parameter that determines the effect of distance
on the transition matrix. The larger the value of ρ, the larger the impact of distance
on the transition probabilities. θ represents all the parameters in the model, including pkl
(k, l = 1, . . . , 4; l 6= k), ρ and all the parameters in the emission distribution. The advantage
of this transition matrix is that it takes the relative positions of windows into consideration.
As the distance between adjacent windows increases, the transition probability from state k
to state l 6= k increases and approaches pkl as dw →∞ (k, l = 1, . . . , 4; l 6= k). On the other
hand, as the distance between adjacent windows decreases, the probability of a difference
in copy number states between windows diminishes, i.e., Aw → I4×4 as dw → 0.
4.3.2 The Emission Distributions
The emission distributions define emission probabilities, which are the conditional prob-
abilities of reference and target read counts, given the copy number state of the window.
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Each window w has two observations, a reference aligned read count U [r]w = u
[r]
w and a target
aligned read count U [t]w = u
[t]
w . We model the reference read count using a Poisson distribu-
tion with mean λ[r]w , i.e., U
[r]
w |λ[r]w ∼ Poisson(λ[r]w ), where λ[r]w follows a Gamma distribution
with parameters α and β.
For the target aligned read count, one natural choice for the emission distribution is
U [t]w |(λ[r]w , Sw = k) ∼ Poisson(Kkc0λ[r]w ), (4.2)
where K1 = 2, K2 = 1, K3 = 0.5, K4 = 0, and c0 is a normalization factor that can account
for any discrepancy between the total number on reference and target reads in normal
regions. However in real data sets, background noise and mis-alignments along the genomic
sequence data are inevitable. For example, within a normal genomic segment, we often see
some windows with target and reference read count ratios significantly higher or lower than
1; within a segment of copy number gain (or loss), we also find windows that have target
and reference read count ratios significantly lower than 2 (or higher than 0.5). The original
HMM introduced above will not only identify real copy number variation signals, but will
also pick local variations caused by random error. In simulation studies, modeling with the
emission distributions as defined above leads to more state changes than true CNV signals.
The problem of identifying too many CNV change points is also pointed out by Ivakhno
et al. (2010). To address this problem, Ivakhno et al.’s CNAseg employs a merging ad-
justment procedure on the outcomes of the original HMM segmentations using Pearsons
χ2 statistics. However, CNAseg segmentation depends heavily of the determination on the
merging threshold. In the method we propose, instead of using (4.2) to model the target
aligned read count distribution, we use a Poisson mixture model for each of the four copy
number states k = 1, 2, 3, 4:
U [t]w |(λ[r]w , Sw = k) ∼
4∑
j=1
qkjPoisson(vkjc0λ[r]w ), (4.3)
where Q = [qkj ]4×4 =

q11 1− q11 0 0
1−q22
2 q22
1−q22
2 0
0 1−q332 q33
1−q33
2
0 0 1− q44 q44

with qkk ∈ (0.5, 1) for k =
76
1, . . . , 4, and V = [vkj ]4×4 =

2 v12 0 0
v21 1 v23 0
0 v32 0.5 v34
0 0 v43 0

with v12, v21 ∈ (1, 2), v23, v32 ∈
(0.5, 1), v34, v43 ∈ (0, 0.5). The parameters qkj (k, j = 1, . . . , 4) are the weights for the
Poisson components in the mixture distribution, vkk (k = 1, . . . , 4) denote the effects of the
copy number variations, and vkj (k, j = 1, . . . , 4; k 6= j) denote the effects of local variations
due to random error.
Based on the model as specified so far, the joint distribution for the target and the
reference read counts at window w, conditional on the hidden state for window w being k,
is
P (∗)(U [t]w = u
[t]
w , U
[r]
w = u
[r]
w |Sw = k,θ)
=
∑
j
qkj
Γ(u[t]w + u
[r]
w + α)(vkjc0)u
[t]
w βα
Γ(α)u[r]w !u
[t]
w !(vkjc0 + 1 + β)u
[t]
w +u
[r]
w +α
=
∑
j
qkjNBU [r]w
(
α,
1
β + 1
)
NB
U
[t]
w |U [r]w
(
u[r]w + α,
vkjc0
vkjc0 + β + 1
)
(4.4)
with u[r]w ∈ Z\Z− and u[t]w ∈ Z\Z−. Here NBy(η, ξ) = Γ(y+η)y!Γ(η) ( ξξ+1)η( 1ξ+1)y is the probability
mass function of the negative binomial distribution with parameters η and ξ. Note that
P (∗)(u[s]w = 0, u
[c]
w = 0|Sw = k,θ) =
∑
j
qkj
(
β
vkjc0 + 1 + β
)α
,
which is greater than 0. We know that it is actually not possible for a window with the
target and the reference read counts to both be zero because sites with both zero reference
and target read counts are not part of the data set. Thus, the joint distribution of u[t]w and
u
[r]
w is truncated in the sense that
P (u[t]w = u
[r]
w = 0|θ) = 0.
As a consequence, we multiply the jth component of (4.4) by a constant (vkjc0+1+β)
α
(vkjc0+1+β)α−βα
(j = 1, 2, 3, 4), and obtain the joint probability for the target and reference reads at window
w given Sw = k:
P (uw|Sw = k,θ) = P (uw|Sw = k, α, β, c0, q,v)
=
∑
j
qkj
(vkjc0)u
[t]
w βα
u
[t]
w !u
[r]
w !Γ(α)
Γ(u[t]w + u
[r]
w + α)
(vkjc0 + 1 + β)u
[t]
w +u
[r]
w
(
(vkjc0 + 1 + β)α − βα
) , (4.5)
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where uw =
 u[t]w
u
[r]
w
 ∈ (Z \ Z−)× (Z \ Z−) \ {(00)} .
4.4 Parameter Estimation Using the EM Algorithm
We use the Expectation-Maximization (EM) algorithm to estimate the parameters in our
model, θ = {p, ρ, α, β, c0, q,v}, where p and ρ are transition probability parameters, and
α, β, c0, q = (q11, q22, q33, q44)′ and v = (v12, v21, v23, v32, v34, v43)′ are emission probability
parameters. The aim is to obtain the value of θ that maximizes the likelihood L (θ|u)
where u = (u′1, . . . ,u′W )
′.
4.4.1 Characterizing the E and M Steps
The observed data likelihood function is
L(obs) = L (θ|u) =
∑
s
pis1
W−1∏
w=1
aswsw+1(w)
W∏
w=1
P (uw|s, α, β, c0, q,v). (4.6)
s = (s1, . . . , sW )′ ∈ {1, 2, 3, 4}W is a vector of unobserved states for all the windows along
the chromosome, and pis1 = P (S1 = s1). If the hidden states are known, the complete data
likelihood function can be written as
L(comp) = L (θ|u, s) = pis1
W−1∏
w=1
aswsw+1(w)
W∏
w=1
P (uw|s, α, β, c0, q,v). (4.7)
In these two likelihoods, pis1
∏W−1
w=1 aswsw+1(w) is the probability of that the hidden states for
all the windows on the chromosome are s1, . . . , sW , respectively, and
∏W
w=1 P (uw|s, α, β, c0, q,v)
is the probability of the observed read counts u, given the hidden states s1, . . . , sW .
Given the parameter estimates θˆ
(m)
from the iteration m of the EM algorithm, the E-
step is to evaluate E
S|u,θˆ(m)
(
`(θ|u, s)) the expectation of the complete data log-likelihood
with respect to the conditional distribution of the hidden states S given the observed
data u, with θ = θˆ
(m)
. The M-step is to find θˆ
(m+1)
, the value of θ that maximizes
E
S|u,θˆ(m)
(
`(θ|u, s)). A detailed look at both the E and M steps is provided in Section 4.9.1
of the Appendix.
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4.4.2 Initialization, Convergence, and Prediction of Hidden States
The initial values for all the parameters are defined as follows. In the transition prob-
abilities, we define the initial values p(0) ∆= (p12, . . . , p43)′ = 0.1 · 11×9 and ρ(0) = 0.5. For
the parameters in the emission probabilities, we define q(0)11 = q
(0)
22 = q
(0)
33 = q
(0)
44 = 0.5,
v
(0)
12 = v
(0)
21 = 1.5, v
(0)
23 = v
(0)
32 = 0.75, v
(0)
34 = v
(0)
43 = 0.25, and use the maximum likelihood
estimates of α and β with all sites assigned with “normal” state (state 2) as the initial
values α(0) and β(0).
To obtain the initial value for c0, we proceed as follows. First we calculate the ratio
between the target aligned read count and the reference aligned read count for all the
windows where both u[t]w and u
[r]
w are positive through the whole genome across different
chromosomes. Then we classify these ratios into three groups using K-means clustering and
get three group means denoted M1, M2 and M3. Suppose M1 < M2 < M3, then x
(0)
t is the
total target aligned reads located in the windows belonging to the cluster with mean M2,
and x(0)r is the corresponding total control aligned reads located in the windows belonging
to the cluster with mean M2. After obtaining x
(0)
t and x
(0)
r , we calculate c
(0)
0 using
x
(0)
t
x
(0)
r
.
The probabilities of the four hidden states for the first window pis1 (s1 = 1, 2, 3, 4 and∑4
s1=1
pis1 = 1) are determined by the target and the reference read counts in the first
window. We calculate
R1
∆=
u
[t]
1
u
[r]
1
· x
(0)
r
x
(0)
t
.
If R1 > 1.5, then pi1 = 1, and we assign copy number gain as the initial copy number state
of the first window; if 0.75 < R1 ≤ 1.5, then pi2 = 1, and we assign normal as the initial
copy number state to the first window; if 0 < R1 ≤ 0.75, then pi3 = 1, and we assign copy
number loss as the initial state to the first window; if R1 = 0, then pi4 = 1, and we assign
absent as the initial state to the first window.
For all the other windows Sw (w ≥ 2), we use normal state (state 2) as the initial state.
All the parameters are updated using the EM algorithm described in Section 4.1. The
iteration stops if the difference between θˆ
(m)
and θˆ
(m+1)
is very small, and we obtain the
estimate θˆ = θˆ
(m+1)
of the parameter θ.
After convergence, the conditional probability of each of the four states Pk(w) = P
(
Sw =
k|u, θˆ) (k = 1, 2, 3, 4) is calculated, and the conditional hidden state prediction for window
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w is given by the state that has the largest conditional probability, i.e., Sˆw = arg max
k
Pˆk(w),
w = 1, . . . ,W .
4.5 Adjustments on the Segmentation Result
Aligned sites are grouped into windows at the beginning, because we wish to have
larger read counts to better capture the copy number variation signals in the m-HMM. We
initially assume that the copy number state remains the same within a window. In reality,
it is possible that the copy number change points happen within windows. Figure 4.1
demonstrates the relationship between the estimated changes point before adjustment and
the real change point. Suppose window wb is the location identified by the algorithm from
where the copy number state change from state 1 to state 2 with genomic sites grouped into
windows. We have gwb = {iII , iII+1, . . . , iIII−1}, so iII is the first site in window wb, which
is initially identified as a change point. Window wb−1 and wb+1 are the two windows next
to window wb. With gwb−1 = {iI , iI+1, . . . , iII−1} and gwb+1 = {iIII , iIII+1, . . . , iIV−1}, iI
and iIII are the first sites of wb − 1 and wb + 1, respectively. The real change point i(real)
may happen between sites iI and iIII − 1. In order to obtain a more accurate result, the
following algorithm makes the adjustment.
1. For each site i between site iI and site iIII−1, we obtain the total target and reference
counts from iI to i − 1, denoted as z[t]i(L) and z
[r]
i(L); also obtain the total target and
reference counts from i to iIII − 1, denoted as z[t]i(R) and z
[r]
i(R).
2. Calculate the Pearson’s χ2 test statistic using {z[t]i(L), z
[r]
i(L), z
[t]
i(R), z
[r]
i(R)}.
3. Do step 1 and 2 for each candidate change point between iI and iIII − 1 and the
adjusted breakpoint i(adj) is the one with the largest Pearson’s χ2 test statistic value.
4.6 Simulation Study and Method Comparison
To test the m-HMM methodology, we conducted a simulation study based on real DNA
sequencing data from chromosome 4 of the lung cancer cell line NCI-H2347 from Chiang
et al. (2009). Simulation based on real data can best maintain the characteristic of the
data including noise and errors that exist in real data. We first randomly simulated the
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iI iIII
Real State 1 Real State 2
Estimated State 1 Estimated State 2
Real
Change Point
i(real)
wb ! 1 wb wb + 1
Figure 4.1: Real Change Point and the Estimated Change Point
genomic positions along the target and reference genomes, using a uniform distribution.
Then we generated the reference and target genome read counts by shuﬄing the reference
genome read counts in chromosome 4 of NCI-H2347. After that, we randomly picked 90
CNV segments on the simulated target genome. We considered three sizes for the CNV
segments: 10 kb, 50 kb and 100 kb and generated 10 segments for each CNV type. We
doubled the read counts for the segments with copy number gains, halved the read counts for
the segments with copy number losses and set read counts to 0 for segments with no copies.
In this simulation data set, we have 15668 sites with copy number gains (state 1), 13311
sites with copy number losses (state 3), 6971 sites with no copies (state 4), and 1813984 sites
in normal regions (state 2). We compare the result of the m-HMM with mixture Poisson
emission probability in (4.5), the result using the original HMM with Poisson emission
probability in (4.2), and the result using Segseq by Chiang et al. (2009).
Table 4.1 is the comparison between the original HMM (red) and the proposed m-HMM
(blue). The real number of sites in each states are listed in the last cell of each row. We can
see that the m-HMM identifies 15926 sites with copy number gain state, among which there
are 14375 correct identifications and 1551 false identifications. On the contrary, the original
HMM identifies 54261 sites with copy number gain state, with 13528 correct identifications
and 40733 false identifications. For copy number loss state and absent state, the m-HMM
also identifies more sites with correct CNV states.
Among all the sites identified with CNVs by the m-HMM, 82% of them are correct
identifications and 18% of them are false identifications. In contrast, among all the sites
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identified with CNVs by the original HMM, 23% of them are correct identifications and 77%
of them are false identifications. This means, the m-HMM is less affected by the noise and
errors and can capture the true CNV signals better. Also, the m-HMM identifies over 90%
of all the sites simulated with CNVs, comparative to 83% for the original HMM. Among all
the sites in normal regions in the simulation data, the m-HMM has 99.6% identifications
compared to 94.5% correct identifications of the original HMM. These results highlight the
advantage of the m-HMM approach over the HMM approach.
Table 4.2 lists a comparison between our m-HMM approach (blue) and SegSeq (red).
Segseq classifies the copy number states using only three categories: normal, copy number
gain, and copy number loss, and it does not distinguish between the copy number loss state
and the absent state. In addition, Segseq does not identify any sites with copy number gain
state in this simulation study. Moreover, among the 4754 sites identified by Segseq with
copy number loss or no copies, only 1532 sites are loss or absent sites. Also, Segseq failed
to identify 18750 loss / absent sites.
Predicted States m-HMM
original HMM# Sites Gains Normals Losses Absents Real # Sites
R
ea
l
S
ta
te
s
Gains
14375 1293 0 0
15668
13528 2140 0 0
Normals
1551 1807204 5157 72
1813984
40733 1713862 59388 1
Losses
0 1884 11427 0
13311
0 2315 10996 0
Absents
0 194 85 6692
6971
0 143 1179 5649
Table 4.1: Comparison between the m-HMM and the original HMM
Predicted States m-HMM
SegSeq# Sites Gains Normals Losses or Absents Real # Sites
R
ea
l
S
ta
te
s Gains
14375 1293 0
15668
0 15668 0
Normals
1551 1807204 5229
1813984
0 1810762 3222
Losses or Absents
0 2078 18204
20282
0 18750 1532
Table 4.2: Comparison between the m-HMM and the SegSeq
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4.7 Application
We apply the proposed m-HMM to compare the sequence data from two maize geno-
types: B73 and Mo17. We use the B73 genome as the reference sequence and the Mo17
genome as the target sequence. In the data preparation stage, both the B73 genome and
the Mo17 genome are sampled with 44 bases segments and aligned to the reference B73
genome. We obtained 4.3 million aligned reads from B73 and 1.54 million aligned reads
from Mo17, and we have 2.3 million genomic positions on the reference B73 genome with
positive alignments. Using the m-HMM method, we found 1096 segments of 2000 bases
or longer that have copy number variations that are at least 2 fold increasing/decresing,
among which, Mo17 has 14 segments with copy number gain state, 835 segments with copy
number loss state and 247 segments with absent state, compared to the B73 inbred line.
The most significant copy number loss or absent state detected on Mo17 is in chromo-
some 6 (Figure 4.4), located from 42.2 million base to 46.2 million base on the reference
genome. Within this segment, the reference genome B73 has 8152 total read counts, and the
sample genome Mo17 has 542 total read counts. The copy number ratio is about 0.066, or
0.13 after taking into account the normalization factor c0. Table 4.3 of the Appendix Section
4.9.2 shows the m-HMM segmentation result between 35.3 million bases and 57.0 million
bases. Two other long segments with copy number loss or absent state in chromosome 6 are
from 26.5 million to 28.8 million, and from 47.8 million to 49.7 million. These identifications
are concordant with the result from other studies, in comparing DNA sequences between
B73 and Mo17 using aCGH data (Springer et al. 2009; Belo et al. 2010).
There are several large segments with few or no copy number variations between Mo17
and B73. They are 121.3 Mb ∼ 130 Mb on chromosome 1 (Figure 4.2), 69.2 Mb ∼ 82.0
Mb and 84.8 Mb ∼ 95.9 Mb on chromosome 3 (Figure 4.3) and 49.5 Mb ∼ 61.5 Mb on
chromosome 10 (Figure 4.5). These results are also concordant with previous results using
aCGH data.
Table 4.4 in the Appendix Section 4.9.2 lists the detected CNV segments that are longer
than 2 Mb and have CNV greater than 2-fold changes between B73 and Mo17.
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Figure 4.2: log ratio between the copy numbers of Mo17 and B73 on chromosome 1
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Figure 4.3: log ratio between the copy numbers of Mo17 and B73 on chromosome 3
4.8 Conclusion
In this paper, we proposed a new methodology to detect CNVs in the DNA sequences
from two genotypes using next generation sequencing data. We used a hidden Markov model
incorporating the mixture emission probability model to identify copy number variation
change points. The simulations study suggests that the m-HMM has better sensitivities
and specificities in CNV identifications compared to other methodologies.
The proposed m-HMM was applied to compare NGS data between the two maize inbred
lines B73 and Mo17, and identified CNV change points of the target sequence Mo17 relative
to the reference sequence B73. The result of the m-HMM is concordant with previous
genomic studies using aCGH data by Springer et al. (2009) and Belo et al. (2010).
In addition, the m-HMM can be applied in comparing NGS of two genotypes when only
one target genome sequence and one reference genome sequence are available, while many
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Figure 4.4: log ratio between the copy numbers of Mo17 and B73 on chromosome 6
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Figure 4.5: log ratio between the copy numbers of Mo17 and B73 on chromosome 10
other existing methods require multiple sequences in both target and reference genotypes.
With less data and financial requirement, m-HMM has broader applications in genotype
comparisons using NGS data.
4.9 Appendix
4.9.1 More Details in the EM Algorithm
The EM algorithm is an iterative procedure to find the parameter value θ that maximizes
the likelihood function L (θ|u). The observed data likelihood function is
L(obs) = L (θ|u) =
∑
s
pis1
W−1∏
w=1
aswsw+1(w)
W∏
w=1
P (uw|s, α, β, c0, q,v).
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The complete data likelihood function is
L(comp) = L (θ|u, s) = pis1
W−1∏
w=1
aswsw+1(w)
W∏
w=1
P (uw|s, α, β, c0, q,v).
1. the E step:
The E step is to evaluate the expectation of the complete data log-likelihood with
respect to the conditional distribution of the hidden states S, given the observation
u and current parameter value θˆ
(m)
: E
S|u,θˆ(m)(`(θ|u, s)). The complete data log-
likelihood function is
`(θ|u, s) = log pis1 +
W−1∑
w=1
log
(
aswsw+1(w)
)
+
W∑
w=1
logP (uw|s, α, β, c0, q,v).
The expectation with respect to the conditional probability of the hidden states, given
the observations u and the parameters θˆ
(m)
obtained from the mth iteration is
E
S|u,θˆ(m)(`(θ|u, s))
=
∑
s
P (S = s|u, θˆ(m)
[
log pis1 +
W−1∑
w=1
log
(
aswsw+1(w)
)
+
W∑
w=1
logP (uw|s, α, β, c0, q,v)
]
=
∑
s
P (S = s|u, θˆ(m)) log pis1 (4.8)
+
∑
s
P (S = s|u, θˆ(m))
W−1∑
w=1
log
(
aswsw+1(w)
)
(4.9)
+
∑
s
P (S = s|u, θˆ(m))
W∑
w=1
logP (uw|s, α, β, c0, q,v) (4.10)
=
4∑
k=1
Pk(1) log(pik) +
W−1∑
w=1
4∑
k=1
4∑
l=1
Pkl(w) log(akl)
+
T∑
t=1
M∑
k=1
Pk(t) logP (uw|s, α, β, c0, q,v),
where Pk(w) = P (Sw = k|u,θ), and Pkl(w) = P (Sw = k, Sw+1 = l|u,θ).
We prove the last “=” as follows:
(4.8) =
∑
s
P (S = s|u,θ) log pis1
=
∑
s
4∑
k=1
P (S = s|u,θ)I{S1=k} log(pik)
=
4∑
k=1
Pk(1) log(pik),
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(4.9) =
∑
s
P (S = s|u,θ)
W−1∑
w=1
log
(
aswsw+1(w)
)
=
∑
s
P (S = s|u,θ)
W−1∑
w=1
4∑
k=1
4∑
l=1
I{Sw=k}I{Sw+1=l} log(akl)
=
W−1∑
w=1
4∑
k=1
4∑
l=1
[∑
s
P (S = s|u,θ)I{Sw=k}I{Sw+1=l}I{k 6=l}
]
log(akl)
=
W−1∑
w=1
4∑
k=1
4∑
l=1
Pkl(w) log(akl),
(4.10) =
∑
s
P (S = s|u,θ)
W∑
w=1
logP (uw|s, α, β, c0, q,v)
=
W−1∑
w=1
4∑
k=1
4∑
l=1
P (S = s|u,θ)I{Sw=k} logP (uw|s, α, β, c0, q,v)
=
T∑
t=1
M∑
k=1
Pk(w) logP (uw|s, α, β, c0, q,v).
The numeric values of Pk(w) =
P (Sw=k,u|θ)
P (u|θ) and Pkl(w) =
P (Sw=k,Sw+1=l,u|θ)
P (u|θ) can
be evaluated using the forward-backward algorithm, which was introduced by Ra-
biner and Juang (1986). The forward probability fk(w) is defined as the probability
of having state k at time w, and having the observations {u1, . . . ,uw} from win-
dow 1 to window w, given the parameter θ, i.e., fk(w) = P (u1, . . . ,uw, Sw = k|θ).
The backward probability bk(w) is defined as the probability of having the observa-
tions {uw+1, . . . ,uW } from window w + 1 to window W , given the state k at win-
dow w, the observations from window 1 to window w, and the parameter θ, i.e.,
bk(w) = P (uw+1, . . . ,uW |Sw = k,u1, . . . ,uw,θ). The forward and backward prob-
abilities can be obtained using recursions: fk(1) = pikP (u1|S1 = k,θ), bk(W ) = 1,
fk(w) =
∑4
l=1 fl(w − 1)alk(w − 1)P (uw|Sw = k,θ) for w = 2, . . . ,W , and bk(w) =∑4
l=1 akl(w)P (uw+1|Sw+1 = l,θ)bl(w + 1) for w = W − 1, . . . , 1.
Consequently,
P (Sw = k,u|θ)
= P (u1, . . . ,uW , Sw = k|θ)
= P (u1, . . . ,uw, Sw = k|θ)P (uw+1, . . . ,uW |Sw = k,u1, . . . ,uw,θ)
= fk(w)bk(w),
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and
P (Sw = k, Sw+1 = l,u|θ)
= P (u1, . . . ,uw, Sw = k|θ) · P (uw+1, Sw+1 = l|Sw = k,u1, . . . ,uw,θ)
· P (uw+2, . . . ,uW |Sw = k, Sw+1 = l,u1, . . . ,uw+1,θ)
= fk(w)P (uw+1, Sw+1 = l|Sw = k,θ)bl(w + 1)
= fk(w)akl(w)P (uw+1|Sw+1 = l,θ)bl(w + 1).
2. the M step:
The M step of EM algorithm is to find the value of θ, to make ES|u,θ(m)(`(θ|u, s))
obtain the maximum. And this optimum value is the updated parameter θ(m+1) for
the (m+ 1)th iteration.
ES|u,θ(m)(`(θ|u, s))
=
∑
s
P (S|u,θ)
[
log pis1 +
W−1∑
w=1
log
(
aswsw+1(w)
)
+
W∑
w=1
logP (uw|s, α, β, c0, q,v)
]
=
4∑
k=1
Pk(1) log(pik) +
W−1∑
w=1
4∑
k=1
4∑
l=1
Pkl(w) log(akl)
+
T∑
t=1
M∑
k=1
Pk(t) logP (uw|s, α, β, c0, q,v)
=
4∑
k=1
Pk(1) log(pik) +
W−1∑
w=1
4∑
k=1
Pkk(w) log
(
1−
(∑
l′ 6=k
pkl′
)(
1− e−ρdw
))
+
W−1∑
w=1
4∑
k=1
∑
l 6=k
Pkl(w) log
(
pkl
(
1− e−ρdw
))
+
W∑
w=1
4∑
k=1
Pk(w) logP (uw|s, α, β, c0, q,v)
, G1(pik) +G2(p, ρ) +G3(p, ρ) +G4(s, α, β, c0, q,v).
We take derivative of g2 and g3 with respect to pkl:
∂G2(p, ρ)
∂pkl
+
∂G3(p, ρ)
∂pkl
, 0 (k, l = 1, . . . , 4; l 6= k)
⇒
W−1∑
w=1
(1− e−ρdw)Pkk(w)
1− (1− e−ρdw)∑l 6=k pkl =
W−1∑
w=1
Pkl(w)
pkl
(k, l = 1, . . . , 4; l 6= k).
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Then we get
W−1∑
w=1
Pk1(w)
pk1
= . . . =
W−1∑
w=1
Pk4(w)
pk4
=
W−1∑
w=1
(1− e−ρdw)Pkk(w)
1− (1− e−ρdw)∑l 6=k pkl
for k, l = 1, . . . , 4 and l 6= k.
We ask
∑W−1
w=1
Pkl(w)
pkl
= hk, k = 1, . . . , 4, and find the value of hk that maximizes
W−1∑
w=1
Pkk(w) log
(
1−
(∑
l′ 6=k
∑W−1
w=1 Pkl′(w)
hk
)(
1− e−ρdw
))
+
W−1∑
w=1
4∑
l=1;l 6=k
Pkl(w) log
(∑W−1
w=1 Pkl(w)
hk
(
1− e−ρdw
))
for each k. Then a new p value can be obtained by pkl(w) =
PW−1
w=1 Pkl(w)
hk
, k, l = 1 . . . , 4,
l 6= k. And ρ can be obtained by directly maximize G2(p, ρ) +G3(p, ρ) with respect
to ρ, using the new p value.
After obtaining a pair of values of p and ρ that maximize G2(p, ρ) + G3(p, ρ), we
estimate the values for α, β, q and v by maximizing G4. Iteration continues until all
parameter values getting converged and we obtain an updated θ(m+1) value.
4.9.2 CNV Identifications
Table 4.3: The m-HMM Segmentation Result in Chromosome 6 from 35.3 Mb to 57.0
Mb
Start Position End Position Mo17 Read counts B73 Read counts CN Ratio (Mo17/B73)
35,274,511 36,847,009 1,511 2291 1.33
36,847,028 36,986,070 81 242 0.67
36,988,155 39,227,681 2,375 3850 1.21
39,227,711 39,392,612 53 294 0.36
39,392,816 39,998,180 605 810 1.51
39,998,210 40,070,876 114 95 2.43
40,071,001 42,219,831 1,978 2751 1.45
Continued on Next Page. . .
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Table 4.3 – Continued
Start Position End Position Mo17 Read counts B73 Read counts CN Ratio (Mo17/B73)
42,221,884 42,272,394 3 305 0.01
42,273,061 42,279,935 0 37 0.00
42,281,369 42,467,432 6 484 0.02
42,467,722 42,510,527 0 199 0.00
42,520,362 42,588,228 10 134 0.15
42,589,445 42,592,668 0 16 0.00
42,600,850 42,949,605 41 734 0.11
42,957,788 43,020,977 0 213 0.00
43,021,808 43,021,808 1 0 50.00
43,021,875 43,034,674 0 20 0.00
43,050,012 43,156,464 7 214 0.06
43,159,602 43,239,996 0 110 0.00
43,240,069 43,240,069 4 1 8.11
43,240,496 43,253,531 0 25 0.00
43,270,468 43,367,135 27 396 0.13
43,382,243 43,436,720 0 211 0.00
43,437,634 43,437,634 1 0 50.00
43,437,664 43,438,342 0 19 0.00
43,440,089 43,466,314 8 146 0.11
43,466,499 43,502,281 0 183 0.00
43,502,441 43,502,441 1 0 50.00
43,504,419 43,516,326 0 3 0.00
43,532,757 43,802,344 29 815 0.077
43,802,387 43,809,486 0 214 0.00
43,809,952 43,809,952 4 0 50.00
43,809,982 43,811,684 0 47 0.00
Continued on Next Page. . .
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Table 4.3 – Continued
Start Position End Position Mo17 Read counts B73 Read counts CN Ratio (Mo17/B73)
43,812,791 43,828,685 1 128 0.01
43,833,620 43,862,804 0 121 0.00
43,863,025 43,863,025 1 0 50.00
43,866,525 43,959,900 0 164 0.00
43,959,976 43,960,274 2 10 0.40
43,960,449 43,984,663 0 95 0.00
43,991,670 44,242,537 24 498 0.09
44,247,904 44,297,744 0 50 0.00
44,297,961 44,297,961 1 0 50.00
44,299,769 44,341,066 0 252 0.00
44,341,857 46,215,928 371 2308 0.32
46,215,958 46,834,832 572 895 1.29
46,835,472 47,130,192 74 545 0.27
47,130,202 47,668,306 642 833 1.56
47,681,491 47,739,876 18 72 0.50
47,740,273 47,740,273 0 2 0.00
47,746,723 48,880,371 283 1356 0.42
48,880,568 48,923,056 0 51 0.00
48,923,160 49,722,664 213 1128 0.38
49,722,844 50,132,724 231 298 1.57
50,132,929 50,239,093 28 119 0.47
50,260,756 52,852,085 2,487 3567 1.41
52,852,089 52,958,397 155 130 2.41
52,958,403 53,950,690 918 1453 1.28
53,951,899 56,137,418 895 3196 0.56
56,142,451 56,472,218 296 570 1.05
Continued on Next Page. . .
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Table 4.3 – Continued
Start Position End Position Mo17 Read counts B73 Read counts CN Ratio (Mo17/B73)
56,472,614 56,863,324 102 570 0.36
56,866,117 57,022,366 123 212 1.17
Table 4.4: Large CNV Identifications
Start Position End Position Copy Number Ratio (Mo17/B73)
chr 1 7,674,194 10,130,535 0.47
73,051,891 76,150,311 0.49
78,765,566 80,973,937 0.40
106,020,503 108,085,310 0.46
183,346,370 185,514,363 0.34
185,561,332 187,744,738 0.34
206,016,332 208,795,988 0.49
chr 2 14,327,370 17,154,616 0.49
43,421,667 45,665,032 0.47
53,360,846 57,062,635 0.48
101,464,135 103,592,856 0.37
173,361,552 175,485,424 0.46
183,250,632 186,406,359 0.46
209,163,585 211,227,635 0.48
211,597,012 214,704,617 0.48
chr 3 3,653,572 5,790,383 0.44
Continued on Next Page. . .
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Table 4.4 – Continued
Start Position End Position Copy Number Ratio (Mo17/B73)
45,465,224 48,749,064 0.40
82,020,005 84,053,318 0.48
176,248,175 179,361,747 0.48
chr 4 645 2,454,064 0.45
23,025,833 25,854,581 0.48
136,792,400 140,387,061 0.36
140,502,832 143,245,529 0.49
146,672,844 148,733,733 0.44
239,597,061 242,255,833 0.48
243,186,165 245,433,834 0.49
chr 5 753,941 4,311,600 0.48
5,201,605 7,723,585 0.48
11,328,383 14,574,771 0.49
16,611,265 19,032,650 0.44
68,583,278 71,949,086 0.40
156,325,001 158,697,338 0.47
168,069,569 170,816,075 0.39
176,121,726 179,598,151 0.43
191,459,521 195,013,031 0.48
chr 6 25,898,308 28,476,332 0.33
70,440,134 72,858,938 0.46
76,981,074 80,570,101 0.46
85,620,416 87,659,132 0.48
102,350,617 104,422,628 0.49
154,917,250 159,407,299 0.47
162,488,577 165,722,159 0.48
Continued on Next Page. . .
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Table 4.4 – Continued
Start Position End Position Copy Number Ratio (Mo17/B73)
chr 7 18,304,500 22,673,932 0.49
25,498,467 30,547,169 0.47
78,344,496 81,198,663 0.40
110,502,115 113,262,773 0.49
117,913,056 119,946,052 0.49
120,044,241 122,233,553 0.49
chr 8 20,108,771 23,447,168 0.43
160,011,805 166,514,647 0.45
167,430,533 169,880,960 0.45
chr 9 38,523,842 40,732,642 0.41
46,734,889 49,382,812 0.38
61,499,201 64,577,206 0.39
83,491,462 88,345,837 0.46
118,555,633 121,557,270 0.49
143,196,239 145,630,853 0.45
145,813,631 150,079,829 0.46
chr 10 20,262,176 24,734,243 0.48
39,046,734 41,852,436 0.46
72,370,857 74,553,412 0.42
111,247,775 116,238,001 0.46
117,013,634 120,679,932 0.49
121,011,209 124,203,304 0.49
130,590,451 139,841,271 0.46
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CHAPTER 5. Summary
5.1 General Conclusion
This thesis studied several topics in statistical theories and methodologies related to
biological and genomic areas.
In Chapter 2 and Chapter 3 we focused on statistical inference with order-restricted
hypotheses. Chapter 2 derived the likelihood ratio test (LRT) and the intersection-union
test (IUT) for the hypothesis with the null parameter space constructed by a union of two
cones. The tests can be applied to heterosis identifications, in detecting the case where
the mean trait value of the hybrid offspring more extreme than its inbred parental lines.
We studied the asymptotic power of the LRT and the IUT, and shown that the LRT
is uniformly more powerful than the IUT. We also discuss the situations in which tests
that are uniformly more powerful than the LRT can be constructed. We concluded that,
although the uniformly more powerful test are of interest in a theoretical aspect, these tests
face difficulties in real practical data analyses.
Chapter 3 proposed four procedures to detect multivariate gene sets with changes in
gene expression distributions under quantitative or ordinal treatment factors. The pro-
posed tests focus more detecting power focusing on monotonic changes patterns. The four
proposed tests were compared to other tests, which spread power over the entire alternative
space, with the same power on the monotonic subspace and the non-monotonic subspace.
We found that the proposed tests have higher detection powers when the gene expressions
in multivariate gene set change monotonically. In order to deal with the problem of high
dimensional random vectors and small sample sizes, we proposed to use permutation pro-
cedures to obtain non-parametric statistical inferences in all the testing procedures.
Chapter 4 explored a new methodology to identify copy number variations (CNVs)
between two different genotype lines using next generation sequencing data. The method
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uses a Hidden Markov Model with mixture emission probabilities to detect the CNV change
points. We demonstrate that our proposed methodology improves some existing methods,
with higher sensitivities and specificities.
5.2 Future work
5.2.1 Testing a union-of-cones null hypothesis with an extension on parameter
dimensions
In Chapter 2, we studied tests with null parameter space being a union of two cones,
where each of the cones is defined by two linear combinations with coefficients without
positive relations. In future study, one possible extension that could be made is to test a
union-of-cones null hypothesis with each cone defined by more linear combinations, which
results in two multidimensional polyhedral cones with more parameters involved. When
the number of dimension increased, the null and the alternative parameter spaces are no
longer be able to project on a plate, but the extension study of the likelihood ratio test and
the asymptotic null distribution of the test statistic can be conducted.
5.2.2 copy number variation detections using next generation sequencing data
with corporations of single nucleotide polymorphism (SNP) information
In Chapter 4, we proposed a new methodology in copy number variation detection
with next generation sequencing read counts. Based on genomic knowledge, copy number
variations usually occur accompanied by single nucleotide polymorphisms (SNPs). SNP is
a variation of DNA sequence on single nucleotide, Adenine (A), Cytosine (C), Guanine (G),
or Thymine (T), which is the basic building block. In future work, we can make use of this
SNP information, for a further improvement on the accuracies and the efficiencies of the
CNV detections.
